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INTRODUCTION 
Manganese has long been known to be a constant component of 
both plant .and animal tissues ( Bertrand and Medigreceanu, 1913 ) .  The 
requirement of manganese in plant and microorgani sm metabolism was 
proven by McHargue ( 1923 ) .  Later investigations by many individuals 
have shown the requirement of manganese in animal metabolism.  There 
has been a great deal of research in the &rea of manganese require-
ments ,  although, the enumeration of all of the pos sible and specific 
-
.actions in which manganese plays a part has not been completed . 
Manganese may perform many biological functions and has been 
shown by many investigators to be involved in the biosynthetic enzyme 
systems as well as the hormonal systems . Little understood and , as 
yet ,  incompletely outlined was the effect manganese had on the altera-
tion of the hemogram parameters and the function of the element in 
erythropoiesis . 
The obj ectives of these investigations were to determine the 
effect of manganese on the following: red and white blood cell 
counts , differential counts , packed cell volume, hemoglobin, reticulo-
cyte composition, and manganese and iron determinations in respect to 
possible changes in these measurements with prolonged exposure to 
manganese . 
1 
REVIEW OF LITERATURE 
MANGANESE PATHWAY 
The presentation of the large mass of material such as  that 
represented by research in the area of manganese and its physiological 
aspects would have been pointle ss in this review, but , since many 
changes in mammalian systems are reflected in the blood parameters, a 
review of some of the actions of manganese was required.  
Manganese is an element of the transition group having a mol-
ecular weight of about 54. 9 and, more importantly, having a number of 
oxidation states . This ·element is  easily oxidized or reduced, adding 
difficulty to the study of the specific oxidation state which might be 
important in a particular reaction. Further complicating the picture 
in biological processes is the similarity in the in vitro actions of 
manganese and magnesium and their differences in vivo ( Cotzias , 1961). 
The pathway of manganese through the body has been well studied 
and outlined . The primary route of manganese absorption was observed 
to be through the gastrointestinal tract by Mena et al . '(1969 ) .  The 
specific site of absorption was shown to be the small inte stine by 
these same re searchers .  Under iron load and normal dietary manganese 
the duodenum, j ejunum, and the ileum passively absorbed similar 
amounts . Under normal iron concentrations the duodenum and ileum had 
� 
a slight , nonsignificant, increase in absorption rate, while with iron 
deficiency this difference became significant ( Thomson, Olatunbosun, 
and Vallberg, 1971 ). Thomson � �· ( 1971 ) also reported that the 
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rate of abs orption was limited with the length of exposure . Some 
researchers and editors (Thomson et al. , 1971; Boyer,  Lardy, and 
Myrback , 1960) indicated that the percentage of manganese  abs orbed 
from the gastrointestinal tract was influenced by other metallic 
elements such as  iron and calcium. Diez-Ewald, Weintraub , and Crosby 
(1968) have shown that iron concentration altered manganese absorption 
rates while manganese did not influence iron absorption .  Diez-Ewald 
� al. (1968) and Poll�ck et al. (1965) postulated a pos sible shared 
pathway for these two elements . 
Kent and Mccance (1941) observed that approximately 25 percent 
of fed manganese was absorbed . Greenberg and Campbell (1940) showed 
that 3 to 4 percent of orally administered manganese was absorbed 
from the intestinal tract , which was in accordance with earlier pro­
posals (von Oettingen, 1935) and most other data . Experiments by 
Diez-Ewald et al. (1968) , Pollack et al . (1965) , and Thomson et al . 
(1971) demonstrated that iron deficiency or anemia increased gastro­
intestinal absorption of manganese .  
Bertinchamps and Cotzias (1959) proposed that metals of  the 
transition group were bound to a plasma macromolecule such as 
beta-1-globulin. They also observed that non-purified transferrin 
would bind both iron and manganese at non-exchangeable sites and that 
purified transferrin would not . This work was later supported by 
Aisen, Aasa , and Redfield (1969a ,  1969b) and Keefer, Barak, and Boyett 
(1970) . Cotzias  and Bertinchamps (1960) .stated that the specific 
globulin, designated transmanganin, that bound manganese required at 
J 
least two molecules of the globulin per atom of manganese in the 
trivalent state and that its binding would control the site of its 
release . 
Manganese retention in the mammalian body i s  dependent on a 
variety of factors and is  directly related to its excretion rate . It 
was found in early research that the total manganese content of the 
human body was relatively stable over the entire life span ( Bruckman 
and Zondek, 1939). Cotzias and Greenough ( 1958) found that the only 
·-
element that can elute manganese from the body was more manganese , 
suggesting a specific pathway through the body. Later work .by Cotzias 
( 1960) confirmed this postulate . 
Hormonal control of the compartmentalization of manganese had 
been proposed at one time . It was observed by HUghes and ·cotzias 
( 1961) that mineralcorticoids had no effect on either the distribution 
or excretion rates of manganese . They found that glucocorticoi�s 
altered the distribution but not the turnover of manganese. The 
mobilization of manganese by glucocorticoids required an induction 
period, indicating an indirect influence on its disposition and thus 
did not show any sort of homeostatic control . Predni solone and 
cortisol reduced liver manganese concentrations and raised carcass 
values ( Hughes and Cotzias , 1961 ) .  This work was later confirmed by 
Hughes, Cotzias , and Cronkite ( 1962 ). 
· Britton and Cotzias ( 1966) found that the retention of manganese 
was dependent upon its variable excretion rate while its absorption 
was dependent upon and proportional to its dietary uptake. The 
4 
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specific route of excretion was first proposed in work by Bruckman and 
Zondek (1939) to  be through the liver. This proposal was later con­
firmed as a primary pathway by Kent and Mccance (1941), Greenberg , 
Copp, and Cuthbertson (1943), Cotzias and Greenough (1958), Kato 
(1963), and B�rtinchamps , Miller, and Cotzias (1966) . Greenberg and 
Campbell (1940) stated that almost no manganese could be found in the 
urine . 
Many of the foregoing workers found that abs orbed manganese was 
excreted in two "waves", a fast and a slow component . This excretion 
was tied directly to  the entero-hepatic circulation by Borg and 
Cotzias (1 958), Bertinchamps et al . (1966), Papavasiliou, Miller,  and 
Cotzias (1966), and Dastur, Marghani , and Raghavendran (1971). The 
first wave or rapid component was found to be the plasma clearance rate 
of the liver in the.entero-hepatic circulation.  This component cleared 
much of the manganese within 2 minutes and almost all of the manganese 
within 45 minutes of intraportal injection. Borg and Cotzias (1958) 
found that intraportal injection of manganese was almost entirely 
removed in one passage through the liver and linked the removal to the 
biliary excretion rates and passive diffusion.  The second or slow 
component was out of phase  with bile production and was the major 
clearance wave due to the gradient from the plasma to the bile . The 
bile as the major excretion pathway under normal cond�tions handled 
from 50 to 75 percent of the manganese load (Greenberg et al . , 1943). 
Bertinchamps and Cotzias (1 958) observed that bile flow was constant 
following injection,  while the radioactivity peaked then receded to  a 
6 
low plateau, indicative of a rapid equilibrium. Total recovery in the 
first hour was 2 percent of the injected dose and several metal 
chelates �ere found to be present . Secondary routes of manganese 
excretion found under conditions of overloading were the pancreas and 
the small intestine . Burnett et al . (1952) found the pancreas accumu­
lated and excreted small amounts (5 to 20 ug/100 ml) of manganese under 
nonnal or slight load. The rate of excretion was parallel to that of 
protein nitrogen which indicated a relationship between manganese and 
p�ncreatic enzymes. Excretion by the intestine occurred only in small 
amounts and then only under conditions in which biliary excretion was 
stopped or curtailed severely. 
The retention levels of manganese in the body were variable with 
time of exposure and amount. The los s of manganese from the carcass 
also had a double wave , a fast and a slow component . Mahoney and 
Small (1968) found that in man the biological half-life of the fast 
component was 4 days, in which time JO percent of injected radioman­
ganese was excreted. The slow component had a half-life of 39 days 
and consisted of the remaining 70 percent of the manganese load . They 
observed ·that manganese deficiency increased the percent of the slow 
canponent to 84 percent and changed the half-life to 90 days. Mahoney 
and Small (1968) also found that iron deficiency lowered the percent 
excreted by the slow component , preloading with manganese causing an 
even greater effect and neither having much affect on the half-life . 
Dastur � �· (1971) utilizing monkeys, reported that tissue 
losses of manganese were in three groups of discharge rat�s.  These 
7 
discharge groupings could be compared to that of excretion.  The first 
losses were those of the blood , corresponding to plasma clearance and 
tissue uptake and extending over a period of from 2 to 4 days . The 
second grouping, that of cellular and glandular losses , began about the 
fourth day, peaked in the seventh, then receded to a low plateau until 
the loss peaked again at day 17. Other tissues investigated were the 
heart , lungs, muscle, bone, skin, and hair. These tissues' showed the 
same peaking but at lower rates , the muscle tissue having been the s ole 
exception to this , having had a slower discharge rate . The third 
group, the c9ntral nervous system, had the same discharge rate as the 
cellular and glandular group for the first 7 days but instead of 
receding there was a steady low .rate of accumulation. They found in 
this study that half of the radiomanganese was lost in the feces within 
1 week. 
Bruner, Perkinson,  and Hayes (1953) investigated the uptake by · 
various organs in different species . They found with rats that uptake 
by the pancreas was highest followed by that of the liv.er, kidney, and 
the thyroid , 80 percent of which was lost within 96 hours . Guinea 
pigs showed the pancreatic uptake to be the highest followed by the 
thyroid , kidney, and the liver .  Pigs had the highest retention in the 
thyroid .  Dogs had the liver a s  the highest retention in two cases and 
the thyroid in one . These findings definitely indicat�d that distri­
bution was affected by dose , size , species , and individual differences .  
Deysach and Ray (1949) observed the thyroid of the guinea pig 
to have the highest uptake . Maynard and Fink (1956) found that in the 
man and m ou se that th e liv er, pan crea s, and k idn ey s, in d e c rea sing 
ord er, a ccumulat ed manganese and proposed the th eory of a b ound and 
unb ound f ra ct ion w ith in th e b ody. 
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B ritt on and Cotzia s (1966) ob serv ed the accum ulati ons of mangan­
e se i n  th e pa renchymous o rgan s of mi ce with in 2 ho urs with a g reat er 
con cent ration in th e ca rca s s  aft er 2 hours. Kat o (1 96)) r epo rted th e 
mangan ese in mice to be locat ed in th e k idney, pancreas, liv er, and 
intestine afte r 24 hours . Ka t o  (1963) al so ob served peak ex c�eti on 
th rough the f ece s at 10 hou rs f oll owing inj ecti on . Ch ew (1971) found 
no t rend of lo ss or change i n  d isposit ion with temperatu re and no 
ind icat ion of a relation sh ip w ith energy m etabolism, a fa ct or which 
is sign if icant i n  light of th e l ocat ion of int erc ellula r mangan ese 
u ptak e .  
In g ene ral , it c ould b e  seen that th e organs which ac cumula ted · 
mangan ese ra pidly al so lost i t  ra pidly. Usually, th e organ s of ra pid 
a ccum ulat ion w ere th ose whi ch were high in m it och ond ria (B org and 
C otzia s, 1958). Th ey ob serv ed that th e accumulati on· of. mangan ese 
o ccurred at th e m itochond ria and that thi s accumulat ion wa s labile in 
nat ure . Th iers and Va ll ee (1957) reported that mit och ond ria c ollect ed 
la rge c onc ent rations (mola rity 3 x 10-5) in th e rat liv er and tha� the 
nuclei c ontain ed a h igh fra cti on of manganes e, wh ile th e s olub le 
p orti on wa s relat iv ely low in mangan ese . I ron and mangan ese an tag­
oni sm wa s found to be present, in that, th ose a rea s hav ing had a high 
concen trati on of one element w e re l ow in the o the r. Maynard and 
Cotzia s (1955) reported that 66 percent of the 75 pe rcent of cellular 
manganese located in the organelles was ass ociated with the mitochon-
dria. The same researchers suggested manganese as a possible 
respiratory cofactor. Chappel and Grenville (1963) found evidence for 
a possible redox pump in isolated mitochondria. 
The inci�ence of the interchangeability of manganese and 
magnesium in physiological studies in vitro has been noted in many 
studies . Cotzias (1961) published a treatise in which these differ-
ences might be explained. In vitro studies showed that manganese will 
replace magnesium in many enzymatic reactions . Cotzias (1961) stated 
that there was a sharp in � differentiation between these two 
elements , supporting earlier work by Thiers and Vallee (1957) . 
Cotzias (1961) found that lean tissue concentrations of magnesium to 
manganese had a ratio of 2000 : 1 . Further differentiation was found in 
the plasma binding of magnesium to albumin and alpha-2-globulin while 
manganese was bound to the beta-1-globulin portion as a trivalent , 
plasma oxidized conjugate.  Foradori � .21.· (1967) observed that , 
under conditions approximating that of physiological limits ,  magnesium 
bound loosely and nonselectively to serum prote�s and that magnesium 
and manganese were non-interchangeable , adding credance to the biolog-
ioal spaoifioity of each element .  
MANGANESE !@ ENZYME SYSTEMS 
The enzymes and enzyme systems in which manganese �cts as an 
enzyme cofactor in vivo are varied. Manganese has been found to bind 
--
to nucleosid.es and to  relieve blocks in Poly U a.nd Poly A synthesis , 
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replacing magnesium at the binding site (Anderson .£1. al., 1971; 
Kabat, 1967; Wilson, Russo, and Steck, 1970) . Heller, Jones, and Tu 
(1971) investigated manganese interaction with adenosine triphosphate 
(ATP) and found that manganous ions bound at the site of phosphate 
groups and involved some slight interaction with the ring structures. 
The interaction of manganese with pyrophosphate groups and in reac­
tions involving phosphorylation and phosphatase activity was found by 
Cooperman and Mark (1971) and Sumner and Sommers (1953) .  These 
researchers proposed a direct functional requirement for manganous 
ions for those processes to occur. Karpatkin, Braun, and Charmatz 
(1970) observed evidence that manganous ions could activate platelet 
phosphorylase rapidly but suboptimall:y while activation by magnesium 
and ATP was slow but optimal. 
Manganese was linked.with many of the biosynthetic pathways 
found in the body. Papavasiliou, Miller, and Cotzias (1968) observed 
that manganese enhanced both renal and hepatic gluconeogenesis in 
which action cyclic adenosine mono-phosphate (c.AMP) seemed to link 
the metabolism of manganese to that of the amines. Rutman et al. 
(1965) earlier reported the same renal and hepatic stimulation of 
gluconeogenesis from the alpha keto acids. Friedman and Rasmussen 
(1970) suggested that manganese may regulate gluconeogenesis by some 
means other than c.AMP and proposed an increased calcium efflux as the 
mechanism. 
Boyer � !:!• (1960) utilized contributions from a number of 
researchers and listed a variety of enzymes in which manganese, 
10 
at least in vitro, played a role as an activator . Some of those 
enzymes were the alpha amidases, arginase, amylase, dipeptidases,  
peptidase , .. and glycinamide-aminopeptidase . Manganese replaced 
magnesium in many of these reactions . These reactions worked in some 
cases by faster activation with a less stable product such as that 
found with glycinamide-aminopeptidase and in others by merely stabil­
izing the enzyme as with arginase and carbo.xypeptidase . 
11 
Mildvan, Scrutton, and Utter (1966) and Scrutton, Utter, and 
Mildvan (1966) strongly supported the foregoing ,!!!. vitro studies .  
These researchers also provided further evidence showing that pyruvate 
carboxylase tightly binds manganese, replacing tryptophan in the 
activation step and playing an active role in the transfer of the 
carboxyl group from the enzyme-biotin-carbon dioxide intermediate to 
pyruvate. Bach and Whitehouse (1954) and Carvajal � al . (1971) found 
that manganous ions were required to activate and maintain the active 
conformation of liver arginase . Liebholz, Speer,  and Hays ( 1962) 
reported that dietary manganese had no significant effect on liver 
arginase activity. M:mder and Jacobson ( 1964) and Greenberg and 
Lichtenstein (1959) observed that manganous ions activated glutamine 
synthetase by causing the reaction to go to the pH 10 range, whereas ,  
magnesium ions were active over a much wider range including those pH 
ranges within biologic function .  
Curran and Clute (1953) found increased .incorporation of 
sodium acetate into cholesterol in the presence of manganous ions. 
Stern ( 1956) · reported that manganese would form metal chela tea with 
12 
acetoacetic thio esters . Amdur, Rilling, and Bloch ( 1957 ) ·and Scorpio 
and.Ma.sore ( 1968 , 1970 ) found manganous ions to be involved in the 
conversion of mevalonic acid to squaline . Scorpio· and Ma.sore (1968, 
1970) also found that a Mn-ATP complex with acetyl CoA was more active 
than the magnesium complex . Scorpio and Masoro also stated that the 
mapganese complex had no inhibitory effect on polymeri zation of a
1
cetyl 
CoA and that the magnesium complex did.  There was no preferenc e found 
in vivo for either of the ionic elements for this reaction . 
Bentley ( 1951 ) reported that manganous and calcium ions activa­
ted pancreatic enzymes over a period of from 40 to 72 hours and 
prevented deactivation for several hours . Kato ( 1963 ) observed 
similar results and coupled with.Bentley's work might indicate that 
these elements were present to inhibit enzyme autolysis. 
Various researchers ( Deysach and Ray, 1949; Yip and Klebanoff, 
1964 ; Karmarkar and Stanbury, 1967; and Kaellis, 1970 ) have shown that 
manganese plays a role with flavin mono-nucleotide (FMN) and thyroxine 
metabolism ,!!:!. vitro, chelation of monoiodothyronine , uptake and 
storage by the thyroid and its effects in sparing iodine as well as 
raising the level of tissue oxygen uptake . A hypoglycemic reaction 
has been found to result with manganese induction and might indicate a 
synergic interrelationship between manganese and insulin . 
MANGANESE TOXICITY 
The requirements and possible metabolic  involvements of manga-
nese have been explored in detail . Toxic and pathological conditions 
of manganese excess,  while described as to symptomology, have not yet 
been elµcidated as to mode of action at the biochemical or cellular 
level to any great detail. 
Acute manganese overload at a level of 20 mg of manganous 
sulfate for each 100 g or body weight was induced in rats by 
Witz.leben et !.!..· '{ 1968 ). The overload caused an acute hepatocellular 
necrosis with i nterhepatic cholestasis. 
The prevalent type of manganese overload was chronic in· nature 
and has been well documented by Cotzias (1962 ) ,  Cotzias �al . ( 1968 ) ,  
and von Oettingen (19 35).  
Mena�£· (1969 ) ,  in  an investigation into chronic manganese· 
poisoning of miners ,  outlined the pathway by which manganous dusts 
enter the system. These researchers found that manganous dusts 
entered the lungs and were transferred to the intestine for absorp­
tion. Tracer studies with 5�c12 and 
54Mn2 o3 showed lung retention 
for 2 4  hours followed by a rapid decline in this area and their 
appearance successivel� in the epigastrium, right hypochondrium, and 
hypogastrium. Radioactivity at a level of 60 percent of the adminis­
tered dose was found in the feces within 4 days of inhalation. Mena 
et al . (1969 ) summarized their findings by stating that anemia will --
elevate tissue concentrations and by linking the absorption of manga-
nese to that of iron. 
:i0844Q SOUTH DAKOTA STATE UNIVERSITY LIBRARY 
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MANGANESE IN HEMOPOIESIS 
Orten et �· (1933) published work in which manganese was 
found to partially reduce the toxicity of prolonged cobalt treatment 
and the resuitant polycythemia. It was discovered that this element 
14 
had a stabilizing influence on hemoglobin, red blood cell counts and . . ' 
cell and blood volumes. 
Deficiency studies by Wachtel, Elvehjem, and Hart (1943) showed 
a gradual decrease for hemoglobin values to 2 g/100 ml below.normal 
and problems in hemoglobin regeneration with anemia. Ellis, Smith, 
and Gates (1947) observed no changes in the bl�od parameters using 
manganese deficient rabbits. 
Gubler et al. (1954) reported a microcytic, slightly hypo-
chromic, anemia with a concurrent slight· elevation in reticulocytes 
in rats administered MnC12• These researchers were interested in 
manganese-copper interaction and proposed the theory that manganese 
interfered with the retention of copper and the hemopoietic function 
of copper. Hartman� Matrone, and Wise (1955) reported.a depressed 
hemoglobin f onnation with high levels of dietary manganese and felt 
that the anemia was the result of manganese-iron antagonism at the 
absorption site. Sullivan (1960) recorded experiments in which adult 
rats that were fed manganese edetate had a significant reduction in 
hemoglobin but not in mean corpuscular hemoglobin concentration or in 
mean corpuscular volume. Pre-adult rats in the same experiment 
became miqrocytio and juvenile rats showed bypochromia. Sullivan 
concluded that there was little or no change with adults and that a 
severe but reversible anemia resulted in the young. Moinuddin and 
Lee ( 1960 ) fed mangano�s sulfate to rats and elicited a reduced 
15 
hemoglobin.with a concurrent polycythemia .  Baxter, Smith, and Klein 
( 1965) initiated an acute manganese excess in rats and found an eleva-
ted hemoglobin percent within 10 hours with a peak between 12 and 18 
hours . The hemoglobin elevation was concurrent with an increased 
packed cell volume and mean corpuscular vqlume and showed anisocy-
tosis and hypochromia,  as well as , a slight basophilic stippling . 
Cunningham, Wise, and Barrick ( 1966 ) utilized calves fed vari-
ous levels of manganese and found no significant difference in the 
hemogram parameters within 84 days . They observed after 100 days 
that there was a significant decrease in hemoglobin and that higher 
levels of manganese had a more pronounced effect. While acute or 
short term ma.nganism has been shown to play some significant role in 
hemogram changes , long term chronic ma.nganism and its effect on �ryth-
ropoiesis was ,  perhaps,  of more importance .  
Early work on chronic manganism was reviewed by Kesic and 
Hausler ( 1954 ) and some conclusions were made from that review and 
their own research and observations . Kesic and Hausler quoted Scander 
8:lld Sallam as saying, "The erythrocyte count was normal , as well as , 
the leucocyte total and differential counts . The red cells are all of 
normal size and shape with no signs of degeneratione" Kesic and 
Hausler ( 1954 ) reported a quote by Paddy of Flinn on twenty-three 
worlanen exposed to manganese dusts as , "In general , leucopenia became 
more pronounced with the progress of the disease , as an examination of 
the case records revealed that all but one of the welY advanced .cases 
had leucocyte counts of less than 5 , 000 . There was an absolute rela­
tive neutropenia in four cases in the affected group; i.e., not only 
is the percentage of neutrophiles decreased, but the total white cell 
count is low in each case, being 4 , 300 or less." They found, "no 
significant variations in red cell counts and hemoglobin estimations, 
in bleeding or coagulation time, in blood platelet or reticulocyte 
counts." 
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Other authors quoted by Kesic and Hausler ( 1954 ) were as 
follows: Faught examined nineteen workers and found lnanganese affect­
ed workers had low leucocyte counts involving the neutrophilic cells, 
Schwarz and Pagels described erythrocytosis and elevated hemoglobin 
values, while Beard and :Mrers reported that manganese may supplement 
the action of iron in nutritional anemia, causing some polycythemia 
and increasing erythrocyte maturation rates. 
Kesic and Hausler ( 1954) concluded from source review and their 
own investigations that early manganism demonstrated inc.reased eryth­
ropoiesis and depressed monocyte values. The authors also found no 
changes in hemogram parameters but did not exclude the possibility of 
anemia occurring in severe chronic poisoning. 
The explanation as to how or where manganese entered the eryth­
ropoietic function was investigated by Borg and Cotzias. (1958 ) .  These 
researchers injected a manganese tracer in man and found that after 68 
days almost all manganese remaining was in the erythrocytes. Follow� 
ing hemolysis they observed that the manganese was non-dializeable and 
not available for chelation. Weed and Rothstein ( 1960) supported 
this work on mature human erythrocytes ,  finding that uptake was 
passive but that 40 to 60 percent of the uptake was non-ultrafilter­
able and less than 5 to 10 percent of the manganese was bound to the 
stroma. 
The incorporation of radiomanganese into duck erythrocytes was 
studied in vitro by Norris and Klein ( 1961) . They found the uptake 
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to be reversible until X-radiated, whereupon it stopped or slowed , 
indicating that uptake was mainly by reticulocytes .  Some of the 
manganese was recoverable as heme , supporting the hypothesis that some 
manganese porphyrin complexes were being formed. Cotzias and 
Papavasiliou ( 1962) reported manganese was bound more firmly with 
erythrocytes than plasma . Lindskog and Thyman ( 1964) described a 
very loose binding with human carbonic a.nbydrase , indicating the 
possibility that manganese was principally bound inside the red blood 
cell rather than at the stroma of the cell . Cotzias, Miller , and 
Edwards ( 1966) injected manganous sulfate and found the expected rapid 
serum clearance with a small portion remaining and exhibiting a slow 
decline with the erythrocyte fraction parallel to the life span of the 
red blood cells .  Mahoney and Sargent ( 1967) reported red blood cell 
uptake of radiomanganese in preincubated human blood in which 0 . 5  
to 9 . 0  percent was irreversible and of which 60 to 70 percent was 
recovered as crystalline hemin . These results indicated that the 
manganese was bound in the heme fraction of the red blood cell . 
Loach and Calvin (1964), Fabry, Simo, and Javakerian (1968), 
Davis and Montalvo (1969), and Watennan and Yonetani (1970) investi­
gated manganese metalloporphyrins and found that manganese binds with 
apohemoglobin in the valence of plus three. They also found that 
manganese metalloporphyrin1s stability decreased severely below pH 7 
and that the metalloporphyrin showed no oxygen or carbon dioxide 
binding capacity and reduced the affinity_ of the hybrid iron subunits 
for either oxygen or carbon dioxide . 
MEASUREMENT .QE. HEMOGRAM PARAMETERS 
Many fine texts and handbooks on the methods of diagnostic · 
hematology were available. Cartwright (1968) was used in this study 
for the common techniques for packed cell volume, hemoglobin, corpus� 
cular constants, performance of Wright's stain, and background 
material for the electronic counting of cells. Ce"11 identification 
for the differential counts was based on descriptions and pictures in 
Bloom and Fawcett (1968). 
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Reticulocyte stains and collllts were performed by a te chnique as 
publ1shed by Bracher (1949) and Bracher and S chnideman (1950) using a 
new methylene blue stain. 
MANGANESE DETERMINATION � BIOLOGICAL SPECIMENS 
The methods used in measuring the manganese content of bio­
logical materials vary in difficulty and in accuracy. The most common 
methods are those involving periodate and catalytic methods. 
The periodate method involved the oxidation of the ash sample 
to a stab�e permanganate in a periodate solution. The method as out­
lined by Mehlig ( 1938) was of average accuracy having had an optimal 
range of from 0 . 07 to J.O ug. Mehlig found little significant inter­
ference with other common ions since these were removed in the course 
of determination-. Sulfuric , nitric ,  and phosphoric acids , as well as 
excess periodate would not interfere with the spectrophotometric 
determination over a wide range of readings. 
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The catalytic methods of manganese determination were varied 
and contained inherent error possibilities. The most popular cata­
lytic method employed permanganate . Sandell ( 1959 ) reported this 
mechanism, catalytic combustion with 4, 4'-tetramethyldiaminotriphenyl­
methane and digestion with nitric�perchloric acid and nitric-sulfuric 
acid. These methods,  accurate to 0.01 ug, were diff�cult and the 
readings had to be taken rapidly due to the rapid deterioration .of 
the permanganate color. 
Bacteriological determination of manganese was best outlined in  
work by Bentley, Snell, and Phillips ( 194 7) 5 Removal of ·manganese 
from the substrate was carried out by Lactobacillus arabinosus . Dry 
ashed sample was added to the medium and the growth of the .!!· 
arabinosus was measured by electrotitration of the lactic acid con­
tent. This method was accurate in the range of from 0 . 05 to 0. 5  ug 
of manganese . 
Cotzias ( 1962) has presented an extremely accurate technique of 
neutron bombardment which can measure quantities of manganese to as 
little as 2 . 5  x lo-3 ug. Cotzias et al . (1966) publi shed information 
as to the methods of handling blood and serum for the neutron activa­
tion technique . 
Flame spectrophotometry was a relatively accurate method, 
although it required a high degree of handling . Iida and Fuwa 
(1967, 1968) outlined the proper technique with this method and 
gave the possible areas in which error may enter the system . Flame 
spectrophotometry was the technique used in this ·research and the 
source and methods have been presented in the appropriate section . 
A prerequisite to most of the listed analytical techniques was 
the ashing of the sample by some method and the removal of ions other 
than manganese which might have had interference value in the spectro­
photometric determination. Down and Gorsuch ( 1967) reported a tech­
nique of wet ashing with 50 percent hydrogen peroxide and refluxing 
of the same , which they found accurate and subject to small error . 
Bolton, Cavender , and Stack (1962 ) published a method of dehydration 
and dry ashing used in this research as it was modified by Wade 
(1972) which was presented in the appropriate section of methods and 
material s. · 
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EXPERIMENTAL PROCEDURE 
SELECTION OF EXPERIMENTAL ANIMALS 
The �imals used in the experimental groups were Dutch Belted 
rabbits of the South Dakota State University stock, weighing between 
1330 and 2600 g and averaging approximately 1850 g. Thirty-two intact 
males were selected at random and placed into four test groups with 
animals of each group approximating the same weight. 
All subject animals were housed individually in stainless steel 
cages . The animals were provided with pelletized rabbit rationl and 
water ad libitum . The trial period was during the winter months , but, 
thermostatic control of the room temperature prevented wide fluctua-
tions of temperature . 
EXPERDAENTAL GROUPS 
Each group was injected intraperitoneally (IP ) every 7th day 
following the sampling with either a physiological saline solution 
or an aqueous carrier of manganous chloride. All doses were calcu-
lated to give an injection level of 5 ml/kg of body weight . 
The initial experiment was designed with two manganese treat­
ment levels and a saline control. High mortality in the high man-
ganese group and incidental losses in the other groups made it 
necessary that the design be changed . The intermediate manganese 
I 
level was instituted and animals were added as needed to other groups . 
lRalston Purina co . ,  St .. Louis , Missouri. 
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Group 1 (saline control) received the IP injection of physio­
logical saline, following sampling, at a rate of 5 ml/kg of body weight. 
Group 2 (low-level manganese) received manganous chloride in 
aqueous carrier IP at a rate of 2.5 mg Mn/kg of body weight. 
Group 3 (mid-level manganese) received an IP injection of 
manganous chloride in aqueous carrier at the rate of 5 . 0  mg Mn/kg of 
body weight. 
Group 4 (high-level manganese) received manganous chloride at 
.. 
the rate of 10 . 0  mg Mn/kg of body weight. 
SAMPLING, EQUIPMENT, AND TREATMENT 
Glassware used in the blood manganese and iron determinations 
was treated with a 3 normal HCl bath for not less than 3 hours then 
washed and rinsed three times with double distilled-deionizec water 
before oven drying. Removal of all traces of metal contamination was 
a requirement for accurate manganese and iron determinations. 
Blood samples were taken by cardiac puncture, removing 2 . 5 cc 
at each sampling. The syringes employed were of the disposable 
plastic type, 2 . 5 cc in size with 22 gauge needles. The syringes were 
heparinized with a wash of sodium heparin in a 2 mg/ml of solution 
immediately prior to sampling. The blood was placed in glass sample 
tubes (14 mm x 75 mm ) into which 1 , 000 IU of soaium heparin had previ 
ously been placed. The blood and the anticoagulant were immediately 
mixed to prevent rapid sample deterioration and coagulation. All 
parameters which might deteriorate were performed within 6 hours. 
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Stock treatment solutions were prepared from research grade 
MnC12-4 H2o and double distilled-deionized water for eaeh of the 
treatment· groups. The stock solutions were prepared so as to have 
2.5, 5.0, and 10.0 mg of manganous ions in each 5 ml of carrier. 
' 
Following the blood sampling procedure the specified dosage of mangan-
ese or saline was administered by IP injection. 
HEMOGRAM DETERMINATI ONS 
The erythrocyte and leucocyte counts were performed with the � 
Coulter Counter Model F2 using the standard technique as set forth in 
the Coulter Instruction and Service Manual (5th edition). Dilutions 
were carried out using the Coulter Counter Du.al-DiluterJ with Isoton4 
as the diluent. Zap Isoton5 was used in place of saponin for counting 
white blood cells. The red cell counts were corrected for error 
employing the Coulter Counter Coincidence Chart6• 
The cya:nm.ethemoglobin method? and Hycel standard and reagents8 
2Coulter Electronics, Inc., Hialeah, Florida. 
JCoulter Electronics, Inc., Hialeah, Florida. 
4coulter Electronics, Inc. , Hialeah, Florida. 
5coulter Diagnostics, Inc., Miami Springs, Florida. 
6coulter Electronics, Inc., Hialeah, Florida. 
7cyanmethamoglobin Determinations, Hycel, Inc., Houston, Texas. 
8 Hycel, Inc., Houston, Texas. 
were used to perform the hemoglobin determinations . Readings were 
determin�4 utilizing a Beckman DB-G Grating Spectrophotometer9 . 
Samples no:t yielding identical values were discarded and perfonn.ed a 
second time . 
Packed cell volumes ( PCV ) were carried out by the microhemato-
crit method . tm 10 An. Adams Autocrit Centrifuge was used and Yankee 
Micro Hematocrit Tubes11 were employed.  Duplicat.e. samples were done 
using the same basis of sample acceptance as given for the hemoglobin 
determinations . 
Differential counts were done by using the dry smear and . the 
Wrights stain techniques o The cellular counts were executed under 
high dry with 645X magnification. The microscope employed was the AO 
Spencer four obj ective with the AO Spencer Ortho-Illuminator12 • The 
differential count involved the five basic categories : neutrophiles , 
basophiles, eosinophiles,  lymphocytes, and monocytes .  Five replica­
tions for each sample were done and no further differentiations as to 
the age or condition of the cell types were made. 
9Beclanan Instrwnents , Inc . , ' Fullerton, California. 
10c1ay Adams, Inc. , New York, New York. 
11c1ay Adams, Inc . , New York, New York. 
12.American Optical Co . , histrument Division, Buffalo, New York. 
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NEW METHYLENE rn TECHNIQUE 
The reticulocyte count was accomplished by the new methylene 
blue stain (Brecher, 1949 ) . The �tain was prepared by combining 0. 5 g 
of new methylene blue ( color index 927) with 1 . 6  g of potassium · 
oxalate and 100 ml of distilled-deionized water. 
Equal amounts of blood (heparinized sample) and stain were 
mixed on a slide , drawn into a 0 . 1  ml pippette and allowed to stand 
for 10 minutes .  The preparation was then expelled onto a slide for 
remixing and a dry smear was prepared for counting . Five hundred 
cells were counted using a Miller ocular and the AO Spencer micro­
scope . Duplicate counts were performed and the counts were computed 
to percent reticulocytes . 
MANGANESE Mill, l!ll?li DETERMINATIONS 
The manganese and iron determinations were done in a two step 
method . The dry ashing of the plasma and formed elements was carried 
out in accordance with a procedure published by Bolton, Cavender, and 
Stack (1962) as modified by Wade (1972) . · A pooled blood sample of 
10 ml was centrifu.ged and separated into fonned elements and plasma . 
Each portion was added to its own 50 ml crucible . Concentrated 
sulfuric acid (1 ml) was added to each sample to form a stable sulfate 
base and 1 ml of hydrogen peroxide was also added to prevent spatter­
ing. The samples were then placed in a drying oven for approximately 
4 hours at 120 C to reduce the volume 2 ml. Samples were then 
removed to a hot plate with �hich the temperature was plowly raised 
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over a 4 hour period to remove all moisture . Prevention of spattering 
was accomplished through the use of high intensity heat lamps placed 
10 cm above and directed at the samples upon the hot plate . The 
samples were then placed in a muffle fUrnace1 3  at 600 C for 6 hours 
for ashing . Samples were removed from the f'urna.ce and cooled away 
from the tray to prevent contamination while cooling . Concentrated 
HCl in the amount of 1 ml was then added to the crucible after which 
the sample was brought to a 10 ml volume by washing the solution from 
the crucible into a grade d test tube . The formed element sample was 
diluted once more by taking t ml from the former ste p and diluting to 
10 ml for the iron determination . 
The iron and manganese d$tenninations were accomplished on a 
Perkin-Elmer Atomic Abs orption Spectrophotometer Model JOJ
14 modified 
by a triple slot burner. A Perkin-Elmer Concentration Readout Meter 
( DCR1B)
15 was used for the iron readings. The 10X scale expansion 
with the noise suppressor set at 2 was used for manganese readings. 
The standards for iron were prepared from a stock solution of 
100 ppm . The standards for iron were
' 
diluted to 0 .5, 1 ,  5, 10, 20, 
and 25 pµn . The s tandards for manganese were prepared from research 
grade MnC12
-4 �O and double distilled-deionized water to 0 . 05, 0 . 1,  
0 . 2, and 0. 5  ppm. S tandards were prepared prior to each sample run 
1�  
' 
Thermo Electric Manufacturing Co. , Dubuque, 
14
Perkin-Elmer C orp . , Norwalk, Connecticut. 
15
Perkin-Elmer C orp. , Norwalk, Connecticut . 
I owa • 
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to prevent losses due to container adsorption • . All tests and settings 
were performed in a ccordance with the methods as set forth by the 
instruction manual. 
RESULTS AND DISCUSSION 
OBSERVATIONS 
Observation of test animals in manganese treatments demon­
strated a gradually increasing toxic influence ·  as indicated by 
scruffy hair coats and general listlessness . There appeared to be 
little resistance to the trauma incurred during samplings in the 
high level test group. A post-mortem analysis of animals not sur­
viving treatment and sampling procedures revealed the cause of the 
deaths to be due to cardiac tamponade or fibrillation, a possible 
symptom of poor muscle tonus and/or trauma resistance . 
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Conrad and Baxter { 1963 ) reported a suppressed heart rate with 
rats following inj ection of manganous chloride subcutaneously. 
Sabatini-Smith and Holland ( 1969 )  in studies of the role of calcium 
ions on rabbit heart rate discovered manganese to have a direct nega­
tive inotropic effect on calcium with complete suppression at higher 
levels  of manganese . Yanga and Holland ( 1969 ) reported similar results 
and complete disappearance of electrical potential at high levels of 
manganese . 
Decreased feed intake and increased water intake were found in 
the higher test levels supporting work by Moinuddin and Lee ( 1960 ) in 
which they induced similar reactions to manganese intoxication. 
Raw data from hemogram parameters and reticulocyte counts for 
this investigation have been presented in appendix table 1 . Raw data 
for iron and manganese determinations have been presented 1D appendix 
tables 2 ,  3 ,  4,  and 5 .  The least squares analysis  o f  variance for 
all data has been presented in appendix tables 6, 7 ,  and 8 .  
� BLOOD CELLS 
Statistical analysis of red blood cell concentrations ( RBC ) 
revealed non-significant changes with treatment , ti.me, and treatment 
by time interaction. The variance of animals within treatments ,  used 
as the error mean square, was too large to allow significance . to 
treatment or time analysis . 
The plotted values for RBC treatment means· ( figure 1 ) evidenced 
wide fluctuations from sample to sample . The plot also exhibited 
generally decreasing values with similar peaks and depressions with 
the exception of treatment 2 ( low-level manganese ) and treatment J 
( mid-level manganese ) . Treatment 2 plotted as high fourth and fifth 
sample mean values with a rapid recession to the sixth sample . 
Treatment 3 had no wide variations above or below the overall mean 
until its acute increase in the sixth sample . Treatment 4 ( high-level 
manganese ) expressed a rapid early elevation to the second sampling 
followed by a slow steady regression in the RBC sample means . It must 
29 
be remembered, however, that only one animal was represented in the 
final three plots of treatment 4. Were it not for treatment 3,  the 
gradual reduction in RBC may have been attributed to the close individ-
ual confinement · but these sample means indicated no trend as to 
' ' ' 
treatment influence .  
Gubler !:! !!_. ( 1954 ) noted � slight increase in RBC with very 
JO 
high levels of manganese inj ections . Feeding trials by other s gave 
similar re sults but did not pinpoint whether manganese interfered with 
erythropoiesis as such or with the intestinal transport of iron . The 
treatment means of this trial , although non-significant , represented 
the control a�
_
having a higher average than group 4 and that group 2 
and J had higher means than the control and overall .means • . 
WHITE BLOOD CELLS 
Examination of data for white blood cell counts ( WBC ) indicated 
highly significant ( P<. 01 )  differenc es in treatment level s but assign­
ed no significance to either time or treatment by · time interaction 
( table 6 ). Comparatively large error mean square prevented signifi­
cance of the latter .two values $  
The control treatment was relatively stable throughout the test 
period , mean values averaging slightly below the overall mean value . 
Treatment 2 vacillated about the treatment mean of 10. 6 x io3;mm3. 
Treatment J,  plotted as the lowest WBC , had the lowest overall 
treatment mean ( figure 2) . Treatment 4 di splayed a rapid depression 
to the second sample , returning to slightly below pre-treatment mean 
in the third and fourth samples . The wide fluctuation in the final 
two plots of treatment 4 might have been a result of the sample size , 
even though the treatment mean was above the overall mean. 
There appeared to be no radical changes in leucocyte numbers 
throughout the test period from pre-treatment levels for any of the 
treatments • . Work by Kesic and Hausler ( 1954 ) reported a slight 
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non-significant depression in leucocyte values .  The highly signifi­
cant difference s  found in treatment levels were evident from the 
JJ 
initial pr�-treatment samples . There were no stati stically s ignificant 
difference s brought about through a given treatment ' s  effect over the 
period of time involved in thi s research. 
PACKED CELL VOLUME 
-
Statistical analysi s  of packed cell volume ( PCV ) data demon­
strated that the treatment was significant C P<. 65 )  while time and· 
treatment by time interaction were not significant . Treatment 1 
( control ) and treatment 2 fluctuated about the overall mean of 43 . 1  
percent and presented similar peaks and recessions . Milder fluctua-
tions were found within the treatment 2 means ( figure J ) . Treatment J 
averaged J perc ent higher than the overall mean but expressed severe 
reduction in the third sample with a gradual increase in values to 
pre-treatment levels . Treatment 4 expressed immediate severe depres-
sion, level ed off to the fourth sample, retreated again in the fifth, 
and returned to the third sample level in the final sampling . 
Treatments J and 4 appeared on ·opposite sides of the mean yet may 
merely have been a reflection of the pre-treatment separation .  
Baxter � !1_.. ( 1965 ) reported increased PCV i n  mild levels of 
mangane se inj ection over a short period of time .. Gubler�!.!.· ( 1954 ) 
reported depressed PCV with high levels of manganese in rats .. Signif­
icant difference s  were observed between treatment level s ' in  this 
research but no differences that mi�ht have been attributed to the 
treatment effects were observed .  
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HEMOGLOBIN 
The examination of hemoglobin ( Hb ) data indicated that time was 
highly significant ( P(. 01 )  and that neither treatment nor treatment by 
time interaction were significant . 
Plotted sample means for treatments 1 ,  2 ,  and 4 maintained 
. .  
their relative place in pre-treatment sample levels . Treatment· 3 was 
similar to the other treatments but did not recover as quickly nor 
recess as far as did the other treatments from sample three to· sample 
six ( figure 4 ) .  The study of treatment means affirmed the control to 
be by far the highest level of Hb .  Treatments 2 and 3 were close to 
the overall mean while treatment 4 was severely depressed . Time 
analysis revealed the decrease in Hb through the samples to be gradual 
with the exception of samples three and four. These samples had wide 
fluctuations which could not be explained as to cause . · 
Kesic and Hausler ( 1954 ) observed elevated Hb values for miners 
exposed to manganese dusts . The injection of manganese by Gubler 
et al . ( 1954 ) and feeding trial by Sullivan ( 1960 ) ,  Cwµd.D.gham et al . 
- - - -
( 1966 ) ,  and Hartman et al . ( 1955 ) reported reduced Hb values . Liter­
ature reviews reported a variety of data with manganese treatment 
from increased Rb through no effect to depressed values, most of which 
went unexplained as to cause . The evidence from this research seems 
to suggest the conclusions arrived at by Sullivan ( 1960 ) which were 
that adult specimens show little , if any, influence with manganese on 
the total hemoglobin production. 
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RETI CULOCYTES 
The statistical comparison of reticulocyte percentages revealed 
the treatment to be highly significant (ll(.01 ) while time and treat­
ment by time we re non-significant ( table 6). The control treatment 
averaged sign�ficantly higher reticulocyte counts than the manganese 
treatment levels. The counts of the manganese treatments averaged 
increasingly lower as the treatment level of manganese increased. · The 
original slow e levation to a peak, highest in control, followed by a 
gradual slow decline in the manganese treatment ( figure 5) may have 
indicated depressed erythropoietic function in those groups . No 
significance was exhibited as to time but the overall time means 
expressed a gradual rise followed by a reduction of JO percent in the 
mean values. 
Kesic and Hausler (19.54) and Gubler � �· (19.54) reported that 
with manganese int oxication the percentage of reticulocytes rose above 
that ·of the control, although, to a non-significant degree . The 
expression of results such as these in this design may have been 
prevented by the loss of subj ect animals in the high level test group. 
The highly significant differences assigned to treatment q.ifferences 
may have been a reflection of pre-treatment differences rather than 
any effect of manganese treatment . 
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MEAN CORPUSCULAR HEMOGLOBIN 
The· examination of mean corpuscular hemoglobin ( MCH ) values 
revealed bo�h treatment and time t� be highly significant ( P<. 01 ) 
and
. 
treatment by time interactions to be significant ( B(. 05 ) 
( table 7) . Control treatment MCH averaged much higher than mangane se 
treatments .  MCH averaged lowest in treatment 2 and progressively 
higher in treatments 4 and .3 , respectively. 
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Mean sample values were plotted ( figure 6 )  wi th wi de vacilla­
tions in the sample to sample changes . The means were found to regress 
from a high average of 20 . 5  micromicrograms to the second sampling . 
· Gradual recovery to slightly above the overall mean value is found 
through the third and fourth samples followed by a reduction to the 
fifth sample . The sixth sample recovered to values slightly above 
the overall mean .  
The corrected stati stical values for MCH evidenced slight 
depression of the control treatment followed by a gradual elevation in 
value s to the fourth treatment . The final two control samples aver­
aged closely about the overall mean and slightly above pre-treatment 
value . The mangane se treatments exhibited an immediate rapid peak 
through the second and third samples followed by a rapid recession in 
the fourth with gradual recovery to the fifth and sixth samples . 
The depression of MCH supported work by Gubler � al . ( 1954 ) 
in which he noted severe depression in
' 
these values following manga­
nese treatment . The results of thi s investigation were not a s  great as 
those found by Gubler ,  but did show that manganese doe s · depress MCH. 
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MEAN C ORPUSCULAR VOLUME 
The mean corpuscular volume (MCV) was determined to be signifi­
cant ( P<. 05) with treatment by time interaction but non-significant 
with either treatment or time. 
Time �hewed no significance at all with wide fluctuations in 
treatments 2 and 4 and a severely decreased value for treatment J in 
the final sampling ( figure 7). Data analysis demonstrated that 
corrected treatment by time val�es for pre-treatment samples averaged 
closely to each other and were followed by wide va cillations in the 
later sample mean values. The control valu� fell off slightly to the 
se cond sample, recovered quickly to the third sample and thereafter 
maintained. close approximation to the overall mean. The manganese 
treatments displayed an original slight in�rease through the second 
and third samplings followed . by a reduction below overall means 
through the fourth and fifth samples with gradual recovery to the 
sixth sample . Treatment 3 was the exception to this general trend and 
showed instead a decline to the sixth sampling. 
Treatment by time interaction demonstrated a cummulative , very 
�lightly microcytic trend over the mid-sampling values despite the 
final sample averages' close approx'imation to pre-treatment values. 
Gubler � .!.l· (1954) also marked depressed MCV but to a much greater 
degree than implied by this research. 
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MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION 
Highly significant ( P� Ol ) differences were found in treatment 
and time an�lysis but no significance was found as to treatment by 
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time interaction with mean corpuscular hemoglobin concentrations ( MCHC ) 
( table 7) . Control values in treatment analysis were , for the most 
part, above the overall mean and treatments 2 and 4 averaged slightly 
below the overall mean ( figure 8 ) . Treatment 3 averaged much further 
below mean values than any of the others and its fluctuations ·appeared 
to be much less than the other groups .. Samplings one, two, and four 
were found to be above the overall mean. Sampling three, apparently 
· due to treatment 4 ,  was depressed far below the mean. Samplings five 
and six showed a gradual declin� in overall values denoting a reduced 
MCHC for these counts � 
Gubler � !.!_� ( 1954 ) reported mildly depressed MCHC values in 
rats .  Overall differences in treatment by time analysi s  indicated 
terminal elevations in MCHC for manganese treatments as . opposed
 to 
depression in the control treatment o It was noted that initial 
regression was found only in the control and that a severe decline in 
values was postponed in the mid and ' high level treatments of manga­
nese . Low-level manganese treatments did not have a:ny severe depres­
sion at all , expressing instead a mild increase in values at the time 
the others decreased. This action may have been indicative of a 
suppressive influence by treatment 2 on hemoglobin concentration 
alterations and a postponement followed by a more severe reduction at 
higher levels or manganese treatment. 
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THE QUANTITATIVE HEMOGRAM 
No significant differences due to treatment influenc e were 
found in �C counts , WBC counts , reticulocyt e counts , PCV, or Hb 
measurements .  It was noted that the �ighest value s of PCV, Hb ,  
reticulocyte s,  and MCHC were found in the control treatment . It was 
also noted that WBC counts were highe st in treatment 4 but lowe st 
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in treatment J .  Treatment 4 was found to b e  lowe�t in .those measure­
ments in which the control level was highest . It was ob served that 
treatments 2 and 3 were opposite in effect, especially in WBC count s ,  
PCV, Hb, MCH, and MCV and may have been indicative o f  a breaking point 
as to treatment effec t o  It appeared that in all . except the WBC count 
that the low-level mangane se depressed while the high-level manganese 
elevated the hemogram value s c  WBC counts demonstrated the opposite 
findings as to treatment effects . 
DIFFERENTIAL COUNT 
The examination of results for the differential counts was 
analyzed here, s eparate from the other hemopoietic functions , as it 
was considered in its qualitative rather than its quantitative 
aspects . 
Table 8 analys-is of variance represented treatment to be highly 
signi ficant ( P<. Ql ) with respect to neutrophile and basophile counts 
and significant ( p� 05 ) as to eosinophile and lymphocyte counts . Time 
was highly significant ( p� 01 ) to only the eosinophile count and was 
significant ( P� 05)  to basophile and monocyte counts . None of the 
differential counts were significant as to treatment by tirhe inter­
actions . There were no statistically supportable alterations in the 
cellular composition of the differential counts . 
Neutrophile treatment means ( figure 9 ) were highest in treat­
ment ), declining through treatments 4, 2, and 1, respectively . 
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Exactly the opposite order of levels was found with lymphocyt es ( figure 
10 ) . Monocyte treatment means ( figure 11 ) were highe st in treatment 2 
and lowe st in treatment 3 with treatments 1 and 4 in b etween . · 
Eosinophile means were highest in_ treatment 1 and lowest in 4 .  Baso­
phile counts were highest in treatment 4 and lowest in J .  
Time analysis exhibited no significant differences with mono­
cyte,  eo sinophile , and basophile counts . Monocyte values were highest 
in pre-treatment sample one 1 regressing rapidly then increasing again 
in sample five only to recede again in sample six . Eosinophile counts 
demonstrated a rapid ,  high peak and basophile s a delayed lower peak, · 
both of which declined in later values,  although the eo sinophiles did 
show recovery in the final sample .  
Kesic and Hausler ( 1954 ) reported statistical significance with 
depressed monocyte values in miners expo sed to manganese dusts . The 
same inve stigators also reported elevated values for e�s inophile s and 
basophile s even though the increase was non-significant in nature . 
The analysis indicated that the variance of animals within 
treatments was large , overlapping the �reatment differences and cancel­
ling treatment influences . No treatment differences could be detected 
with respect to any inflammatory or immunological responses . 
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IRON AND MANGANESE 
Iron and manganese determinations were not paired due to the 
requirements of sample size. Minimal samples were taken and pooled 
into treatment-sample determination groups to prevent changes in the 
50 
hemogram par�eterso  Two determination runs were performed due to the 
· limited capacity
.
of the muffle furnace and for ease of sample handling . 
Analysis of variance for samples in. iron and manganese determinations 
was not carried out due both to the pooling of samples and the 
non-pairing of data . Though not st�tistically supportable ,  the 
determinations gave an idea of trend and reaction to manganese intox-
ication. 
Dale Wade ( personal communication, 1971 )16 establi shed that 
10 ml samples of blood were sufficient for the purposes of iron and 
manganese determinations in both the plasma and formed elements of · 
swine . Analysis of data and source material ( Dittmer, 1961 ) indicated 
that while erythrocyte and plasma concentrations of manganese were 
in the range of 19 ug/100 ml ( 0 . 19 ppm ) and 8 Ug/100 ml ( 0 . 08 ppm ) , 
re spectively, in normal human blood { complete data on rabbit blood being 
unavailable ) the optimal sensitivity of the method employed for manga­
nese was from 2 to 20 ug/ml ( 2 to 20 
'
ppm ) . It was assumed that only 
the upper limits of concentrations would be measured with any degree 
of accuracy . Expansion of the scale readings allowed differentiation 
of the manganese concentrations . 
16Da.le A .  Wade , Department of Wildlife and Fisheries,  Colorado 
State University, Fort Collins, Colorado . 
Optimal limits of iron determination by atomic ab� orption 
spectrophotometry were in the range of from 2 t o  20 ug/ml (2 t o  
51 
20 pµn) . · Most of the raw determination samples ( table 2) fell in or 
close t o  this range . C orrections for dilution and for the percent of 
each fraction ( plasma or formed elements ) in the original samples were 
carried out and the data was presented in table 4. 
Figures 12 and 13 r�presented the iron c oncentration in the 
formed elements and in the RBC ( the latter averaged and corr�cted for 
volume ) . It was significant to note that iron measurements in the RBC 
did not coincide �s to  relative levels with the MCHC . It was assumed 
from these comparis ons that the spectrophotometric readings might have 
been in error. 
Initially elevated iron values in the formed element fractions 
( figures 12 and 13) were found to fall off rapidly to the second and 
third samples . Treatment 1 ·displayed a severe depres sion from 
pre-treatment levels of REC iron content to sample three with partial 
recovery to the fifth sample followed by final sample depress ion .  
Treatm�nt 2 exhibited results similar t o  the control though rec overy 
was delayed until the final sample . Treatment 4 showed the same 
pattern as the control but the very depres sed values in samples four 
and six may have been the result of sampling error due t o  the single 
survivor.  Treatment 3 averaged much higher overall values than those 
of the other treatments and showed a recovery to pre-treatment levels 
in sample four. 
Plasma levels of iron ( figure 14) manifested elevations and 
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depressions just the opposite to those of the RBC fraction with the 
exception of the first sample . Treatment l . displayed a depression to 
sample four and gradual recovery to the second sample levels .  Treat­
ment 2 decreased to sample three , recovered to sample five and 
regressed ag��n to the final sample . Treatment J followed the pattern 
of treatment 1 though at higher le�els of about 1 ppm. Treatment 4 
exhibited an initial rise of approximately 4 ppm to the second sample 
followed by a depression then an increase in samples three and four . 
The final two samples  of treatment 4 were lower in value than any 
others . The final samples of this treatment were found to drop below 
the optimal range of the employed determination procedure and were 
considered as very inacc'ura te . · 
Overall observation and practice with the equipment , procedures , 
and contamination possibilities lead this observer to believe that · · 
there were little if any real differences in iron concentrations at 
the various treatment levels .  Initially elevated values for plasma 
iron in treatments 11  2 ,  and 3 were attributable to observed hemolysis 
of an unknown source in those samples .  The highly elevated fourth 
sample of treatment J was due to contamination noticed at the time of 
occurrence during determination. 
Manganese concentrations were found to be consistently at or 
below the levels of optimal sensitivity of even the, lOX scale expan­
sion. Lower levels of the
' 
concentrations involved high levels of 
"noise " interference which were sufficient to alter the actual concen-
tra tions to 20 p'ercent or more ·  
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�e most obvious facet of the primary determinations in table 
3 was that , although not uniformly lower, the RBC fraction averaged 
much less than the plasma concentrations of manganese . Many of the 
determinations for formed elements fell below the noi se level and did 
not record any concentrations . It was for this  reason that no plots 
of these values were included in this study . Table 5 presented the 
concentrations expected from the primary determination corrected to 
the original samples . 
RBC concentrations of manganese were revealed to increase with 
treatment level in the first determinations . Treatment 4 showed 
evident second wave excretion levels and erythrocyte uptake in weeks 
three through five . Second run samples indicated no such increase 
with time , signifying instead a more rapid turnover of manganese or 
suboptimal concentrations and noise interference .  
Plasma levels o f  manganese in the first determination displayed 
no wide variation in the treatment 1 or treatment 2 values .  Treatment 
4 was elevated in values for samples three through six, due possibly 
to a second wave excretion of manganese . The second determination run 
of treatments 1 and 2 exhibited fairly consistent zero values for 
plasma while the values for treatment 3 may have been representative 
of some second wave excretion.  
Overall study of  treatment results,  even though non-significant 
or stati stically analyzable , implied a relative increase in manganese 
uptake for erythrocyte s with increased levels of manganese . The 
plasma data supported the proposition of a second wave excr
etion 
--
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prolongation with increased manganese exposure . The only contradicto­
ry evidence was that found with the expected concentrations of manga­
nese in blood and plasma as published by Dittmer ( 1961 ) and presented 
earlier in this sectiono This observation may have been due to species 
differenc es and not to any real alterations in compartmentali zation. 
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SUMMARY 
An attempt was made to determine and compare changes of the 
hem:>gram parameters, reticulocyte counts,  and relative .iron and manga­
nese proportions in the plasma and erythrocyte fractions of the blood . 
Rabbits were admini stered manganous chloride at various levels by IP 
inj ection to accomplish these comparisons . 
Intact ma.le Dutch Belted rabbits over 4 months of age and from 
lJJO to 2600 g were selected and·- placed on a ration of pelletized 
rabbit chow and water fed ad libitum . The treatment groups were 
randomly assigned after group separation and weight equalization . 
Control treatment 1 received 5 ml of physiological saline for each kg 
of body weight . Manganese treatments 2 ,  J ,  and 4 received 2 . 5 , 5 . 0, 
and 10 . 0  mg of manganese for each kg of body weight , respectively, on 
a weekly basis succeeding sampling for a total of six samples .  
RBC counts ,  WBC counts , PCV, Hb percent, .and differential 
counts were performed according to standard clinical procedures . 
Reticulocyte counts and iron and manganese content of both the plasma 
and erythrocytes were also determined.  MCV, MCH, and MCHC were 
calculated for each sample o  
Data analysis · for all but iron and manganese determinations 
were performed by the least squares analysis of variance .  Highly 
significant ( P(. 01 ) differences were established for treatment; 
WBC counts , reticulocyte , neutrophile, lymphocyte , basophile, MCH, and 
MCHC .  Some highly significa.Tlt ( P(. 01 ) differences were also found for 
time ; Hb percent, eosinophile , and MCHC . Significant ( P(. 05 ) 
differences were demonstrated for treatment PCV and tre�tment eosin­
ophile c ounts and als o for time MCH and time MCV . No other 
relationships were found to be significant . 
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This data signified an altered erythropoietic function at high · 
levels of �nganese and a curtailed hemoglobin production. Little 
alteration was displayed in WBC production except a very slight depres­
sion with time . Slight changes were found in monocyte , eosinophile , 
and bas ophile c ounts but no si�nificant differences were noted . 
Nonstatistical recapitulation of iron and manganese data 
implied a relative iron concentration decrease of a small degree 
subsequent to pre-treatment sampling in both plasma and erythrocytes 
which was probab� due to the sampling itself. Manganese concentra­
tions in plasma were disc overed to follow sec ond wave excretion 
patterns while erythrocytes were observed to accumulate concentra­
tions of the element at high levels of exposure . 
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APPENDIX 
RAW DATA TABLES 1 
ANIMAL, TREATMENT DATA 
Treatment Mas s RBC1 WBC2 PCV Hb.3 Reticulo- Ne Ly Mo Eo B4 
g % cytes 
G roup 1 ,  Animal 1 
1 1750 6 . 80 13 .40 48 17 . 2  1 . 5 69 394 33 3 1 
6 . 80 1 3 . 40 48 17 . 2  1 . 1  60 410 26 2 2 
2 1690 7 . 38 9 . 69 43 15 . 0  1 . 5 72 399 20 7 2 
7 . 14 9 . 26 43 15 . 0  1 . 7 64 408 21 6 1 
3 1730 8 . 19 15 . 00 51 16 . 7  1 . 1  95 374 26 3 2 
8 . 1 1  14 . 30 51 16 . 7  1.3 66 406 26 2 0 
4 1710 7 . 58 1 0 . 71 43 16 . 9 1 . 1  94 365 35 3 3 
8 . 16 1 1 . 1 0 43 16 . 9 1 . 9  76 391 28 2 3 
5 1750 8 . 15 1 0 . 40 45 15 . 4  2 . 1  61 407 29 0 3 
7 . 81 10 . 50 45 15 . 4  1 . 1  70 408 21 0 1 
6 5 .55 8 . 49 41 13 . 8  3 . 5 52 387 57 2 2 
6 .08 8 . 58 41 13 . 8  2 . 5 40 414 44 2 0 
G roup 1 ,  Animal 2 
1 2200 6 . 95 13 . 50 46 15 . 9  1 . 5 39 438 21 0 ·2 
6 . 95 13 . 50 46 15 . 9 0 . 9 39 441 18 2 0 
2 2 180 9 . 25 14. JO 51 13 . 0  o . 8  148 323 13 8 8 
9 . 15 14 . 00 51 13 . 0  0 . 9 138 337 15 5 5 
Group 1 ,  Animal 3 
1 2280 8 . 20 1 0 . 86 45 17.2  0 . 9  91 366 40 2 1 
8 . 20 1 0 . 86 45 17 . 2  0 . 7 95 373 32 0 0 
2 2260 7 . 88 12 . 20 43 14. 8  0 .3 53 429 3 1 1  4 
7 . 88 12 . 30 43 14. 8  0 . 7  58 428 2 10 2 
3 2275 6 . 98 10 . 32 41 13 . 4  1 . 9  53 428 14 3 2 
6 . 36 10 . 00 41 13 . 4  2 . 0  48 426 8 6 2 
4 2270 7 . 58 1 1 . 1 0 44 17 . 9  3 . 1  86 373 37 3 1 
7 . 84 12 . 30 44 17 . 9  2 . 7  82 384 JO  4 0 
5 2360 7 . 08 1 1 . 20 43 14 . 6  1 . 5 86 377 36 1 0 
7 . 03 1 1 . 60 43 14. 6  1 . 1  72 397 30 1 0 
6 6 . 89 1 0 . 37 42 14. 6  0 . 5  53 423 24 0 0 
z . 12 2. 40 42 14 . 6  0 . 2 22 424 24 0 0 
1RBc x 106 /rrrm
3
• 
2wBC x 103 /mm3. 
3Hb g/100ml� 
4Neutrophil, �phocyte , monocyte, eosinophil, and basophil 
numbers/500 count . 
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ANIMAL , TREA'IMENT DATA 
T reatment Ma s s  RBC WBC PCV Hb Reticule- Ne Ly Mo Eo B 
g % cytes 
Group 1 ,  Animal 4 
1 2120 7 . 28 10 . 90 43 14. 6  1 . 5 98 366 31 4 1 
7 . 28 10 . 90 43 14. 6  0 . 8  85 382 28 3 2 
2 2165 7 . 72 9 . 55 46 15 . 9 0 . 5 66 410 9 10 5 
7 . 80 9 . 29 46 15 . 9 0 .5 76 403 9 6 6 
3 2175 5 . 97 10 . 33 42 13 . 8  2 . 1  98 372 24 2 4 
6 . 38 10 . 69 42 13 . 8  2 . 1  106 366 16 2 4 
4 2120 7 . 39 8 . 25 41 1.5 .4  1 . 9  108 345 41 3 3 
6 . 38 9 .22 41 15 .4 2 . 3 116 344 3.5 4 1 
5 6 . 88 ,5 .76 44 14.6 2 . 0 147 291 .50 2 .5 
7 . 11 5 . 88 44 14. 6 3 . 1  129 329 38 1 3 
Group 1 ,  Animal 5 
1 164o 7 . 30 10 . 20 43 18 .7 1 . 1  1.52 312 32 3 1 
7 . 30 10 . 20 43 18 . 7  0 . 9  166 304 28 2 0 
2 1600 8 . 76 10 . 80 44 15 . 0  0 . 7  81 398 13 5 . 3 
8 . 74 10 . 20 ' 44 15 . 0  1 .6 88 383 17 10 2 
3 1.580 6 .44 8. 32 40 12 . 0  4. 0 .54 41 9 22 1 4 
6 . 27 8 . 99 40 12 . 0 3 . 6  66 41 1 20 1 2 
4 1610 6 . 99 8 . 34 39 15 . 8  4 .5  76 392 29 1 2 
6 . 47 8 . 53 39 15 . 8  3 .5 86 353 21 0 0 
5 1630 7 . 65 10 . 53 46 14 . 6  2 . 9 128 343 27 2 0 
7 .• 94 11 . 60 46 14 . 6  2 . 9  144 326 28 2 0 
6 6 . 94 7 .46 43 14. 6  2 . 3  99 346 .54 1 0 
6 . 59 7 .84 43 14. 6  2 . 0 104 351 4.5 0 0 
Group 1 ,  Animal 6 
,5 . 66 36 11 . 6  2 . 3  98 375 23 2 1 1590 8 . 81 2 
,5 . 61 8 0.50 36 11 . 6 1 . 7 107 367 24 2 0 
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ANIMAL , TREATMENT DATA 
Treatment Ma s s RBC WBC PCV Hb Reticule- Ne Ly Mo Eo B g % cytes 
Group 1 ,  Animal 7 
1 1420 7 . 20 10 . 30 43 14. 0  0 . 9 44 431 23 1 1 
7 . 59 1 1 . 30 43 14. 0  0 . 9  38 438 22 1 1 
2 1455 6 . 20 9 . 12 40 13 . 0  1 . 3 73 401 25 0 1 
6 . 30 7 . 94 40 13 . 0  1 . 7 91 385 24 0 0 
3 1540 6 . 71 9 . 27 39 13 . 8  3 . 3 123 351 23 0 3 
6 . 36 8 .41 39 13 . 8  2 . 2  105 373 20 0 2 
4 1475 5 . 99 9 . 38 41 13 .8  1 . 1  80 401 18 1 0 
6 . 01 7 . 91 41 13 . 8  0 . 7 88 399 12 1 0 
5 1510 7 . 16 10 . 90 41 13 . 6  0 . 1 107 376 14 3 0 
7 . 05 9 . 16 41 13 . 6  0 . 7  96 387 16  1 0 
6 7 . 05 9 . 00 42 13.4 0 . 7 71 418 9 1 1 
7 . 20 8 . 67 42 13 .4 0 . 9  74 414 10  1 1 
Group 1 ,  Animal 8 
1 1625 6 . 31 8 . 51 41 13 .4 o . o  48 436 13 2 1 
6 . 60 7 . 50 41 13 .4 0 . 7 36 445 16 2 1 
2 1650 6 . 60 8 . 60 47 . 15 .4  1 . 9  73 409 16 0 2 
6 . 60 6 . 82 47 15 .4 2 . 7  58 426 16 0 0 
3 1670 7 . 05 7 . 89 45 14.4 2 . 3  55 431 13 1 0 
6 . 73 7 . 31 45 14.4 2 . 8 64 417 18 1 0 
4 1750 6 . 33 9 . 71 44 14. 2 1 . 6  90 381 26 1 2 
6 . 53 9 . 52 44 14. 2  1 . 3  106 37.5 18 1 0 
5 1780 6 . 53 9 .44 45 15 . 0  0 . 9  83 392 24 1 0 
6 . 95 7 . 95 45 15 . 0  1 . 1  70 413 16 1 0 
6 . 7 . 22 9 . 92 45 13 .8  1 . 1  38 447 12 3 0 
6 . 99 10 . 20 45 13 .8  1 . 2 38 446 14 2 0 
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ANIMAL ,  TREATMENT DATA 
Treatment Mass  RBC WBC PCV Hb Reticule- Ne Ly Mo Eo B g % cytes 
Group 1 ,  Animal 9 
1 1500 6 . 33 8 . 89 40 13 . 0  0 . 7  90 382 28 0 0 
6 . 77 7 . 86 40 13 . 0  1 . 1  78 401 21 0 0 
2 1435 7 . 83 9 . 22 40 14. 0  2 . 5  107 377 13 3 0 
8 . 19 8 . 97 40 13 . 0  1 . 1  94 392 12 2 0 
3 1450 7 . 08 1 1 . 40 40 13 . 8  3 . 6 1 23 346 30 1 0 
7 . 19 10 . 70 40 13 . 8  2 . 2 146 321 32 1 0 
4 1550 6 . 12 8 . 55 39 13 . 2  0 . 3  129 349 19 1 2 
5 . 94 8 . 32 39 13 . 2  0 . 7  140 341 18 1 0 
5 1540 7 .44 8 . 93 41 13. 2  0 . 9  118  357 23 1 1 
7 . 18 8 . 39 41 13 . 2  0 . 3  102 376 20 1 1 
6 7 . 00 8 . 50 43 13 . 8  1 . 1  109 375 12 3 1 
7 . 15 9 . 13 43 13. 8  1 .5 95 394 8 2 1 
Group 1 , Animal 10 
1 1620 6 . 46 7 . 90 41 13.4 1 . 3  45 366 83 5 1 
6 . 31 7 . 08 41 13.4 1 . 3  .35 392 69 3 1 
2 1625 6 . 42 1 1 . 40 42 13 . 0  2 . 1  70 367 60 3 0 
6 . 32 1 2 . 20 42 13 . 0  1 . 8 64 386 48 2 0 
3 1610 7 ; 38 11 . 50 45 14. 4  2 .4 88 385 24 2 1 
7 . 33 10 . 60 45 14.4 2 . 1  72 406 20 1 1 
4 1645 7 . 30 12 . 90 45 13 . 8  1 . 7  77 401 22 0 0 
7 .53 13 . 20 45 13 . 8  1 . 7 94 390 16  0 0 
5 1650 7 . 76 13 . 30 44 14. 2 0 . 3  134 334 32 0 0 
7 . 95 12. 90 44 14.2 0 . 9  11 6 362 22 0 0 
6 7 .57 9 .27 44 13 .4 1 . 3  86 391 22 1 0 
8 .03 9 . 1 1 44 13 .4 0 . 7  1 00 381 18 1 0 
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ANIMAL , TREATMENT DATA 
Treatment Mas s  RBC WBC PCV Hb Reticule- Ne Ly Mo Eo B 
g % cyte s  
Group 2 ,  Animal 1 
1 2030 7 �·35 10 . 50 44 14. 6 0 . 7 82 403 13 2 0 
7 . 35 10 . 50 44 14. 6  0 . 7  66 416 16 2 0 
2 1935 6 . 81 7 . 60 42 13. 8  0 �'8 17 471 9 2 1 
6 . 83 7 . 59 42 13. 8  0 . 3  22 464 8 5 1 
3 1940 7 . 72 1 1 . 60 40 12. 0  1 . 4 66 417 12 3 2 
7 . 48 12. 20 40 12. 0 1 . 0  52 438 6 2 2 
4 1885 8 . 16 12. 70 40 15 . 0  2 . 5  1 05 353 40 1 1 
8 . 75 11 .80 40 15 . 0  2 . 5  118 348 32 2 0 
5 1910 7 . 43 11 . 60 42 14. 2  1 . 4 44 422 32 0 2 
7 . 36 10 . 80 42 14. 2 1 . 8  58 414 28 0 0 
6 7 . 28 9 . 93 40 13 . 0  2 . 1  58 416 25 1 0 
6 . 78 9 . 08 40 13 . 0  1 . 5 66 407 26 1 0 
Group 2 ,  Animal 2 
1 1920 5 . 94 10 . 00 40 13. 8  1 . 0 103 355 39 2 · 1 
5 . 94 10 . 00 40 13. 8  1 . 1  87 373 38 2 0 
2 1860 6 . 65 10 .40 37 12. 0 1 . 3  90 391 14 2 3 
6 . 62 12 . 90 37 12 . 0  1 . 1  74 410 11  3 2 
3 1820 7 . 55 14. 20 40 12 . 3  0 . 7  51 426 21 1 1 
7 . 42 13 . 00 40 12 . 3  0 .5 56 426 16 2 0 
4 1820 8 . 36 1 1 . 30 38 13 . 6  o . o  78 378 39 3 2 
8 . 72 11 . 00 38 13 . 6  0 . 5  90 380 26 2 2 
5 1840 7 . 19 11 . 30 38 13 . 0  1 . 3  138 330 31 1 0 
6 . 46 10 . 70 38 13 .0  1 . 4  124 350 26 0 0 
6 6 . 06 10 . 50 38 12 . 3  2 . 3  97 368 32 2 1 
5 .83 10 . 60 38 12 . 3  2 . 5  84 388 24 3 1 
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ANIMAL ,  TREATMENT DATA 
Treatment Mas s  RBC WBC PCV Hb Reticule- Ne Ly Mo  Eo  B g % cytes 
Group 2, Animal 3 
1 1830 5 . 60 7 . 02 38 13. 8  1 . 1  48 411 39 0 2 
5 . 60 7 . 02 38 13 . 8  1 . 1  39 424 3.5 0 2 2 1770 5 . 88 1 1 . 40 39 12 . 7  0 . 5  18 462 8 9 3 
6 . 13 12.40 39 1 2 . 7 0 . 3 20 469 4 5 2 
3 1780 6 . 53 10 . 99 41 12.0· 0 . 9  60 406 28 1 .5 
5 . 98 1 0 . 89 41 12.0  0 . 5 72 · 394 28 2 4 
4 1750 8 . 77 1 1 . 30 38 14. 6  2 . 7  128 . 309 60 0 3 
8 . 82 1 1 . 60 38 14.6 2 . 9 142 312 44 0 2 
5 1750 8 . 63 10 . 30 38 1 2 . 0  o . o  1 24 325 49 0 2 
9 . 03 10 . 80 38 12 . 0  0 . 1  107 353 40 0 0 
6 6 . 08 1 0 . 56 35 10 . 4 1 .5 1 17 362 18 2 1 
5 . 60 1 0 . 35 35 10 .4 1 . 9 124 3.53 20 2 1 
Group 2 ,  Animal 4 
1 1 970 8 . 87 14. 80 44 13 . 8  1 .4 1 17 332 48 1 · 2 
8 . 87 14.80 44 13 . 8  1 . 2  1 06 350 42 0 0 
2 1950 7 . 97 8 . 74 44 15 . 0  4 . 0  104 377 14 3 2 
7 . 94 9 . 92 44 15 . 0  1 . 8 1 1 1  37.5 1 0  4 0 
3 1940 6 . 8.5 1 2 . 70 45 14. 2  2 . 0  79 39.5 23 1 2 
7 . 01  12 . 10 4.5 14. 2 1 . 6  96 380 20 2 2 
4 1900 9 . 17 11 . 10 43 17 . 7  4. 1 74 382 43 0 1 
9 . 15 10. 90 43 17 . 7  2 . 1  92 374 34 o· 0 
5 1920 9 . 74 1 1 . 40 42 13.4  0 . 7  99 3.59 42 0 0 
9 . 99 1 1 . 80 42 13 .4 0 . 7  79 387 34 0 0 
6 7 . 36 8 . 4.5 42 13.0  1 . 9  101 368 29 1 1 
· 6 . 64 8 . 60 42 13.0  0 . 7  1 15 363 20 2 0 
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ANIMAL , TREATMENT DATA 
Treatment Ma s s  RBC WBC PCV Hb Reticulo- Ne Ly Mo Eo B 
g % cytes 
Group 2 ,  Animal 5 
1 1750 6 . 44  10 . 50 44 14 . 2  0 . 9 93 368 35 1 3 
6 . 44 10 . 50 44 14. 2 0 . 9 108 360 30 0 2 
2 1640 7 . 22 9 . 04 44 14. 2  2 . 4 67 416 15 1 1 
6 . 93 9 . 42 44 14. 2  2 . 3  74 408 16  1 1 3 1680 6 . 74 8 . 51 41 13 . 6  0 . 5  56 424 18 1 1 
6 . 79 8 . 50 41 13. 6  0 . 9  66 414 18 2 0 4 1670 8 . 03 9 . 32 43 15 . 4  1 . 1  85 354 57 1 3 
8 . 20 9 . 85 43 15 . 4  o . o  73 375 48 1 3 
5 1660 8 . 63 9 . 99 49 15 . 8  1 . 1  67 363 65 2 3 
7 . 93 9 . 27 49 15 . 8  2 . 1  81 364 52 2 1 
6 6 . 65 10 . 35 43 13 . 8  0 . 5  44 424 29 0 3 
6 . 51 9 . 67 43 13 . 8  0 . 3  52 415 32 0 1 
Group 2, Animal 6 
14 . 6  1 1865 8 . 85 12 . 40 46 0 . 9  154 32 9 17 0 . 0 
8 . 49 1 2 . 50 46 14 . 6  0 . 8  142 344 14 0 0 
2 1850 7 . 14 1 1 . 60 47 15 .4 1 . 1  88 378 33 1 0 
7 . 10 10 . 80 47 15 .4 0 . 5 76 399 23 2 0 
3 1825 6 . 76 10 . 70 45 14 .4 0 . 5  169. 314 1 6  1 0 
6 . 81 10 . 80 45 14. 4  0 . 7  144 336 1 8  2 0 
4 20.50 6 . 68 8 . 95 43 13 . 6  0 . 1  103 373 22 2 0 
6 . 57 7 . 62 43 13 . 6  0 . 1  102 378 20 o · 0 
5 . 2090 6 . 43 9 . 30 44 13 . 8  1 . 5 90 396 13 1 0 
6 . }3 8 . 40 44 13.8  0 . 9  88 397 14 1 0 
6 · 7 . 06 10 . 60 46 14. 6  0 . 7  74 406 18  2 0 
7 . 02 10 . 70 46 14. 6  0 . 3  60 416 22 2 0 
RAW DATA TABIES 1 
ANIMAL , TREATMENT DATA 
T reatment Mas s  RBC WBC PCV Hb Reticule- Ne Ly Mo E o  B 
g % cytes 
Group 2 ,  Animal 7 
1 1360 5 . 99 10 . 60 45 13. 6  1 . 7 96 366 37 1 0 
6 . 52 10 . 30 45 13 . 6  1 . 3  106 364 27 3 0 2 1380 6 . 66 11 . 1 0 48 15 .4 2 . 7 96 378 24 1 1 
6 . 66 9 . 94 48 15 .4 3 . 1  114 363 20 1 2 3 1440 7 . 73 11 . 30 47 14. 6  1 . 1  146 319 34 1 0 
7 . 20 10 . 30 47 t4 . 6  0 . 5 131 336 32 1 0 
4 1440 9 . 23 5 .83 48 15 .8  o . o  85 387 27 0 1 
9 . 21 6 . 31 48 15 . 8  o . o  72 409 19  0 1 
5 1410 9 . 49 14 . 20 46 14. 6 0 . 7  151 324 34 1 0 
9 .44 14. 60 46 14. 6  0 . 3  145 318 34 2 1 6 7 .44 1 0 . 60 43 13 . 0  1 . 8 90 375 32 2 1 
7 .47 1 0 . 40 43 13 . 0  1 . 9 84 389 24 2 1 
G roup 2 ,  Animal 8 
1 1490 9 . 92 12 . 90 46 14. 2 0 . 5  88 381 29 0 · 2 
9 . 61 1 2 . 80 46 14. 2 1 . 1  72 406 22 0 0 
2 1570 8 .59 12 . 60 49 15 . 8  0 . 5 1 02 364 33 1 0 
8 . 67 1 3 . 00 49 15 . 8  0 . 8 115 351  32 2 0 
3 1590 7 . 33 1 1 .50 45 14.4 0 . 9  78 382 38 0 2 
7 . 76 1 2 . 30 45 14. 4  0 . 3  86 386 28 0 0 
4 1610 8 . 71 1 1 . 90 47 15 . 0  0 . 9  83 400 16 0 1 
9 . 13 12 . 30 47 15 . 0  0 . 5  98 379 22 0 1 
5 1630 9 . 42 13 .60 46 14. 6  0 . 7  101 380 15 .3 1 
9 ., 00 1 1 . 90 46 14. 6  1 . 0  87 394 16 2 1 
6 8 . 25 13 . 00 47 14. 8  0 . 3  67 418 11  2 2 
8 . 32 12.,50 47 14. 8 0 . 1  80 403 14 2 1 
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ANIMAL , TREATMENT DATA 
Treatment Mass RBC WBC PCV Hb Reticulo- Ne Ly Mo Eo B 
g % cytes 
Group 3 ,  Animal 1 
1 1 860 7 . 70 1 1 . 50 47 14 .4 1 . 7  99 366 33 1 1 
7 . 04 1 0 . 40 47 14.4 2 . 0 1 18 366 24 1 1 
2 1895 7 . 84 9 . 24 46 15 . 0  1 . 3 69 405 21 4 1 
7 . 58 9 . 78 46 15 . 0  1 .4 72 41 0 1 2  4 2 
3 1800 7 . 75 1 1 . 70 45 14. 6  0 . 3  128 345 24 1 2 
7 . 67 12 . 80 45 14. 6  0 . 3 146 331 22 1 0 
4 2000 7 .48 9 . 59 45 14. 4  0 . 9  48 437 15 0 0 
7 . 52 10 . 20 45 14.4 0 . 9  ' 54 434 12 0 0 
5 196o 7 . 68 1 1 . 50 43 13. 8  1 . 3 70 410 19 1 0 
7 . 64 10 . 50 43 13 . 8  1 . 1  77 406 15 2 0 
6 7 . 47 8 . 99 47 14. 6  0 . 9  55 422 23 0 0 
7 . 59 8 . 24 47 14. 6  0 . 9 45 437 18 0 0 
Group 3 ,  Animal 2 
1 1925 6 . 45 6.49 41 13.2  0 . 5 132 340 28 0 . o 
6 . 65 6 . 50 41 13 . 2  0 . 7  151 328 21 0 0 
2 1815 8 . 97 8 . 99 42 13 . 0  1 . 1  209 260 25 5 1 
8 . 99 8 . 01 42 13 . 0  1 . 2  212 267 18 3 0 
3 1830 6 . 40 8 . 04 40 13 . 0  1 . 3 153 329 15 3 0 
6 . 72 7 . 09 40 13 . 0  0 . 5  140 ' 340 1 8  2 0 
4 1810 6.42 7 . 60 41 13 . 6  0 . 7  2 1 1  274 14 1 0 
7 . 07 7 . 21 41 13 . 6  0 . 9  222 259 18 1 0 
5 1810 6 .55 6 . 92 42 13 . 0  1 . 3 134 340 23 2 1 
6 . 63 6 . 31 42 13. 0  0 . 9  131 350 16 2 1 
6 7 . 04 6 . 59 42 13 . 0  0 . 9  147 323 29 1 0 
7 . 16 6.81 42 13 . 0  0 � 6  164 314 2 1  1 0 
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ANIMAL ,  TREATMENT DATA 
Treatment Mass  RBC WBC PCV Hb Reticule- Ne Ly Mo Eo  B g % cytes 
Group J ,  Animal J 
1 1890 6 . 78 8 . 98 45 14 . 4  2 . 7 69 4-05 26 0 0 6 . 74 8 . 77 45 14 . 4  1 . 7  80 394 26 0 0 2 1840 7 . 33 8 . 67 47 15 . 0  o . 8 78 395 26 1 0 
7 . 33 8 . 57 47 15 . 0  1 . 1  72 4-09 18 1 0 J 1860 6 . 92 1 1 . 20 44 13 . 4  1 . 3 53 433 14 0 0 6 . 89 8 . 46 44 13 . 4  1 . 3  58 426 1 6  0 0 4 1840 7 . 1 1 7 . 71 41 13 . 0  0 . 2  1 18 365 1 6  1 0 7 . 18 6 . 1 9 41 1J . O  o . o  1 06 381 12 1 0 5 1850 7 . 15 9 . 44  44 13 . 6  1 . 1  95 398 6 1 0 
6 . 87 8 . 44  44 13 . 6  0 . 9  96 393 10 1 0 6 7 . 19 8 . 16 45 14. 2  1 . 7 69 41 1 18 2 0 
6 . 91 7 . 96 45 14. 2 0 . 9  85 J97 16 2 0 
Group 3 1 Animal 4 
1 1 670 6 . 54 6 . 22 43 13 . 6  0 . 7 72 404 20 4 0 
6 . 57 6 . 60 43 13 . 6  1 • .5 80 404 14 2 0 
2 1 620 6 . 25 7 . 86 45 14.4 2 . 3  97 372 31  0 0 
6 . 26 7 . 27 45 14 .4 1 . 6 96 370 32 2 0 
3 1630 7 . 12 7 . 32 45 14. 0  0 • .5 97 397 13 2 1 
6 . 89 6 . 92 45 14. 0  1 . 1 1 14 370 14 1 1 4 1 750 7 . 76 9 .47 42 14. 6  2 . 5  90 386 22 1 1 
8 . 88 10 . 80 42 14 . 6  2 .4 109 371 18 1 1 
5 1490 7 .20 8 . 64 46 14. 6  1 . 4 88 384 28 0 0 
6 . 89 7 . 65 46 14. 6  1 . 1 101 371 28 0 0 
6 7 . 85 7 . 63 47 · 15 . 2  0 . 7  129 339 29 1 2 
7 . 26 8 .49 47 15 . 2  0 . 7  134 343 22 1 0 
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ANIMAL, TREATMENT DATA 
Treatment Mas s  RBC WBC PCV Hb Reticule- Ne Ly Mo Eo B 
g % cytes 
Group 3,  Animal 5 
1 1 660 6 . 92 10 . 30 44 14. 6  1 . 9 141 332 25 1 1 
7 . 05 9 . 46 44 14. 6  1 . 4 1 62 319 17 1 1 
2 1670 7 . 30 1 1 . 20 45 15 . 0  o . 8  196 276 26 1 1 
7 . 19 1 0 . 90 _ 45 15 . 0  1 . 0 174 305 19 1 1 
3 1660 7 .47 1 2 . 40 43 14 . 2  1 . 1  167 319 14 0 0 
6 . 91 13 . 70 43 14. 2  0 . 9  161 329 10 0 0 
4 17.50 7 . 76 9 . 52 43 14. 2 0 . 3  140 326 30 4 0 
7 . 84 1 0 . 30 43 14. 2  0 . 5  134 344 21 1 0 
5 1740 7 . 49 1 0 . 70 44 14. 2  0 . 9  131  343 23 3 0 
6 . 89 9 . 01 44 14. 2  0 . 3  1 1 8  364 16  2 0 
6 7 . 25 9 . 33 43 13 . 8  0 . 5  85 403 1 1  . 1 0 
6 . 52 1 0 . 00 43 13.8  0 . 1  84 401 14 1 0 
Group J ,  Animal 6 
1 1600 6 . 54 1 0 . 50 45 1L� . 4  0 . 5  125 364 8 2 . 1 
6 . 92 10 . 40 45 14. 4  0 . 7  124 361 1 3  1 1 
2 1.580 6 . 88 9 . 66 45 15 . 0  2 . 1  12.5 327 45 3 0 
7 . 1 1 10.40 45 15 . 0  1 . 3  124 326 48 2 0 
3 1610 5 . 26 5. 62 31 10.5  0 . 3  94 384 2 1  0 1 
s . 29 4 . 72 31 10 . 5  0 . 9  1 12 366 20 0 2 
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ANIMAL ,  TREATMENT DATA 
Treatment Ma s s  RBC WBC PCV Hb Reticule- Ne Ly Mo Eo B g % cytes 
Group 3 ,  Anima l 7 
1 2600 7 . 63 9 . 29 47 15 . 2  1 . 9  130 346 24 0 0 
7 . 53 9 . 36 47 15 . 2  0 . 9  1 1 6  360 24 0 0 
2 2500 8 . 60 1 0 . 50 47 15 . 8  1 . 9  1 09 357 30 2 2 
8 . 63 9 . 34 47 15 . 8  0 . 7  1 1 2 363 22 2 1 
3 2410 6 . 81 7 . 78 44 14. 0 0 . 5  141 334 2 1  2 2 
6 . 67 7 . 74 44 14. 0  0 . 9  1 26 352 20 1 1 
4 2400 7 . 49 8 . 14 46 15 . 0  2 . 8  146 328 24 1 1 
6 . 80 7 . 80 46 15 . 0  3 . 5  130 339 28 2 1 5 2390 7 . 35 7 .41 47 15 . 0  0 . 7 1 29 343 27 1 0 
7 . 24 6 . 85 47 15 . 0  0 . 7 1 26 354 1 9  1 0 
6 7 . 42 1 1 . 00 43 14 . 2  o . o  137 347 14 2 0 
7 . 05 9 . 6.5 43 14. 2  0 . 3  130 354 14 2 0 
Group J ,  Anlinal 8 
1 1 820 8 . 07 8 . 78 47 15 . 8  0 . 9 86 382 32 0 . 0 
7 . 96 8 . 65 47 15 . 8  0 . 7 82 388 JO 0 0 
2 1800 8 . 27 1 1 . 90 45 15 . 0  3 . 0 81 372 45 2 0 
8 . 05 1 2 . 60 45 15 . 0  1 . 9 95 368 36 1 0 
3 1750 7 . 28 8 . 1 1  44 14. 6  2 . 1 87 390 22 0 1 
6 . 96 7 . 50 44 14. 6  1 . 9  74 395 30 0 1 
4 1725 7 . 59 9 . 92 46 15.0  1 . 3  121 360 19 0 0 
7 . 35 8 . 72 46 15 . 0  1 . 9 135 337 28 0 0 
5 1710 7 . 99 1 1 .40 46 15 . 0  0 . 9  95 378 25 2 0 
7 . 90 10 . 80 46 15 . 0  1 . 7 84 396 18  2 0 
6 7 . 84 9 . 44  48 1 5 . 6  0 . 3  90 393 14 3 0 
8 . 10 9 . 79 48 15 . 6  0 . 5 102 387 10  1 0 
Treatment Mas s RBC 
g 
Group 4 ,  Animal 1 
1 2270 5 . 75 
5 . 75 
2 2180 7 . 91 
7 . 60 
3 2155 7 . 47 
7 . 27 
4 2190 6 . 47 
6 . 98 
5 2270 6 . 90 
6 . 21 
6 6 . 65 
6 . 48 
Group 4 ,  Animal 2 
1 1750 7 . 20 
7 e 20 
2 1620 8 . 74 
8 . 41 
3 1625 7 . 36 
7 . 32 
Group 4, Animal 3 
1 1750 7 . 38 
7 . 38 
2 - 1670 8 . 82 
8 . 27 
3 1625 8 . 03 
8 .5.3 
RAW DATA TABLES 1 
A.NI , TREATMENT DATA 
WBC PCV Hb Reticule-
% cyte s  
12 . 05 46 15 . 2  1 . 1  
12 . 05 46 15 . 2  1 . 1  
13 . 20 41 13 . 8  0 . 9  
12 . 40 41 13 . 8  0 . 7 
13 . 80 42 12 . 7 1 . 4 
14. 20 42 12 . 7  1 . 7 
12 . 20 41 14. 6 0 . 7  
1 1 . 30 41 14. 6  1 . 1  
1 1 . 00 39 12 . 7  0 . 9 
10 .40 39 12 . 7  0 . 1  
11 . 70 41 13 . 0  0 . 5 
1 1 . 90 41 13 . 0  0 . 5 
9 . 29 41 13 . 0  1 . 2 
9 . 29 41 13 . 0  1 . 0  
1 0 . 50 37 1 2 . 0  1 . 1  
1 1 . 50 37 12 . 0  1 . 1 
10 . 02 39 1 1 . 3 1 . 3 
10 .40 39 1 1 . 3  0 . 9  
14 . 80 49 13 . 8  1 . 1  
14. 80 49 13 . 8  1 . 3 
13 . 1 0 43 14 . 6  1 . 1  
1 2 . 50 43 14. 6  0 . 9  
11 . 60 41 12 . 0  1 . 2 
1 1 . 90 41 12 . 0  0 . 7  
81 
Ne Ly Mo Eo B 
64 414 18 3 1 
5 9  415 20 4 2 
79 401 15 2 3 
78 41 3 1 1  6 2 
90 387 2 1 0 2 
1 10 368 18 2 2 
1 17 344 36 3 0 
128 326 44 2 0 
75 393 30 0 2 
70 406 24 0 0 
72 396 25 4 3 
90 . 384 20 5 1 
109 352 36 1 . 2 
92 373 31  0 4 
105 360 16  5 4 
124 354 16 4 2 
91 367 37 3 2 
97 370 29 4 0 
92 366 41 0 1 
76 386 38 0 0 
149 339 8 2 2 
130 360 8 1 1 
1 18 355 20 2 5 
108 362 27 1 2 
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ANIMAL, TREATMENT DATA 
Treatment Mass RBC WBC PCV Hb Reticule- Ne Ly. Mo Eo  B g % cytes 
Group 4 ,  Animal 4 
1 1780 5 . 75 12. 30 J8 12. 7 1 . 0  71 41 1 15 2 1 
5 . 75 12. 30 J8 12. 7  1 . 0 70 413 17 0 0 
2 1690 6 . 54 5 . 82 J8 12 . 3  o . o  J4 436 24 4 2 
6 G 54 6 . 70 J8 12. J  o . o  36 436 24 2 2 
Group 4, Animal 5 
1 2100 7 o 17 14. 28 44 14. 8  2 . 2  102 J66 JO 1 1 
7 . 17 14. 28 44 14. 8  1 .4 99 J6J J6 1 1 
2 1840 8 . 1 1  7 .43 52 18 . 2  1 . 1  104 J81 10 2 J 
8 . 24 7 . 96 52 18 .2  0. 7  1 15 J69 12 J 1 
Group 4,  Animal 6 
1 1940 5 . 96 10 . 72 J8 13 . 0  0 . 9  47 440 11 2 0 
5 . 96 1 0 . 50 J8 13 . 0  0 . 9  . J8 449 11  2 0 
2 1730 6 . 07 13 . 90 J4 11 . 6  1 . 9  1 1 2  374 6 5 . J 
5 0 6) 12 . 90 J4 1 1 . 6  2 . 5  140 344 10 5 1 
Run 
1 
1 
1 
1 
1 
1 
1 
Run1 
2 
2 
2 
2 
2 
2 
Sample 2 
1 
2 
3 
4 
5 
6 
Sample 2 
1 
2 
3 
4 
5 
6 
RAW DATA TABIES 2 
IRON DETERMINATI ON 
Group 13 Group 24 
Plasma 6 F onned 7 Plasma Fonned 
2 . 9  1 1 . 8  3 .4  6.4 
2 . 9  5 . 8  3 .4 3 .3 
2 . 4  2 . 8  1 • .5 4. 1 
1 . 4 4.2  1 .4 3 .4 
1 . 7 4. 9 2 . 0  2 .5 
2 .5  1 .4 1 . 2 2 . 3 
Group 13 4 Group 2 
Plasrna6 Formed7 Plasma Fonned 
13 . 0  12. 6 7 .4 8 . 2  
2 o 4 3 . 6  1 . 1  3 . 3  
1 . 0  2 . 3  0 . 7 1 . 6  
1 . 3 2 . 2  1 . 6  1 . 8  
1 . 6 3 .4 1 �4 1 . 9  
1 .4 3 . 8  0 . 7  3 . 1  
Grou� 45 
Plasma Fanned 
2 .5 7 . 8 
4 . 2  3 . 0  
1 . 1  1 . 5 
o . 6  0 . 3  
0 .2 o . 6  
0 . 2  0 . 3 
Group 3 8 
Plasma Formed 
6 . 6  1 3 . 4  
3 .4  4 .2  
2 .4 4 .4  
1 .8 11 . 8  
2 . 1  5 . 5  
. 2 . 6  4 .8  
1Determination group. 
2 Sample period : i . e . , sample was on a 7 day basis . 
)Saline control. 
4Low level manganese test group. 
5High level manganese test group. 
6Plasma concentrations of iron in parts per million. 
?Formed element concentrations of iron in parts per million. 
8rntermediate level manganese test group. 
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Run 1 Sample 2 
1 1 
1 2 
1 3 
1 4 
1 5 
1 6 
RAW DATA TABLES .3 
MANGANESE DETERMINATI ON 
Group 1.3 Group 24 
Plasma6 Formed? Plasma Formed 
0 . 055 o . ooo 0 . 153 o . ooo 
0 . 070 o . ooo 0 . 072 o . ooo 
0 . 020 o . ooo 0 . 068 o . ooo 
o . ooo o . ooo 0 . 102 0 . 020 
0 .093 o . ooo 0 . 069 0 . 040 
0 . 099 o . ooo 0 . 060 0 . 056 
Group 45 
Plasma Fanned 
0 . 062 o . ooo 
0 . 0 15 0 . 055 
0 . 030 0 . 160 
0 . 082 0 .048 
0 . 049 0 . 037 
0 . 047 0 . 012 
Run1 Sample2 Group 13 4 Group 2 8 Group 3 
2 
2 
2 
2 
2 
2 
Plasma� Fonned7 Plasma Formed Plasma Fanned 
1 o . ooo o . ooo o . ooo ' o . ooo 0 . 038 
2 o . ooo o . ooo o . ooo o . ooo 0 . 031 
3 o . ooo o . ooo o . ooo o . ooo 0 . 022 
4 o . ooo o . ooo o . ooo o . ooo 0 . 067 
5 o . ooo o . ooo 0 . 051 o . ooo 0 . 034 
6 o . ooo o . ooo o . ooo o . ooo o . ·054 
. 1oetermination group . 
2sample period : i. e . , sample was on a 7 day basis . 
3saline control� 
41ow level manganese test group. 
5High level manganese test group. 
o . ooo 
o . ooo 
o . ooo 
o . ooo 
o . ooo 
o . ooo 
6Plasma concentrations of manganese in parts per million. 
?Fonned element concentrations of manganese in ppm. 
8rntermediate level manganese test group. 
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RAW DATA TABIES 4 
IRON CONCENTRATIONS IN ORIGIN.AL SAMPLES 
1 2 
Run Sample Group 13 Group 2 4 Group 45 
Plasma 6 Formed? Plasma Formed Plasma Fonned 
1 1 5 . 27 525 .33 5 . 86 304 .76 4 . 36 365 . 62 
1 2 5 .31 255 .51 5 .78 160 . 19 8 . 13 124. 14 
1 3 4. 17 128 .73 2 . 56 198 . 07 3 . 03 122 . 95 
1 4 2 .40 201 . 20 2 . 35 168 . 31 5 . 08 73 . 17 
1 5 3 .06 220 .22 3 .44 119 . 62 1 . 63 153 . 85 
1 6 7 .24 109 . 52 1 . 99 116 . 16 1 . 64 73 . 17 
1 2 
Run Sample Group 13 Group 24 8 Group 3 
2 
2 
2 
2 
2 
2 
Plasma6 Formed? Plasma Formed 
1 21 .74 626 . 86 
2 4 . 16  170 .41 
3 1 .73 108 . 88 
4 2 .25 104. 14 
5 2 .79 159 . 06 
6 2 .48 174. 71 
1Determination group� 
2 1 . d Samp e perio • 
3Saline control. 
22 . 64 
3 . 52 
2 . 13 
4. 93 
4. 28 
2 . 12 
41ow level manganese test group. 
5High level manganese test group. 
600 . 00 
229 . 17 
116 . 06 
130.43 
138 . 39 
227 . 65 
Plasma Formed 
11 . 97 597 . 21 
6 .21  185 . 64 
5 . 86 209 .52 
3 . 18 543 .42 
3 . 80 246 .01 
4 .73 213 . 33 
6Plasma concentrations of iro� in parts per million. 
?Formed element concentrations of iron in parts per million. 
8rntermediate level manganese test group. 
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RAW DATA TABIES 5 
MANGANESE C ONCENTRATI ONS IN ORIGINAL S AMPLES 
1 2 Run Sample Group 13 4 Group 2 Grou� 45 
1 
1 
1 
1 
1 
1 
Run 
1 
2 
2 
2 
2 
2 
2 
Plasma6 Formed7 Plasma Formed 
1 0 . 100 o . ooo 0 . 264 o . ooo 
2 0 . 128 o . ooo 0 . 122 o . ooo 
3 0 . 036 o . ooo 0 . 116 o . ooo 
4 o . ooo o . ooo 0 . 171 0 . 050 
5 0 . 168 o . ooo 0 . 119 0 . 09.5 
6 0 . 284 o . ooo 0 . 099 0 . 141 
2 Group 13 4 Sample Group 2 
1 
2 
3 
4 
5 
6 
6 
' 
Plasma F onned 7 
o . ooo o . ooo 
o . ooo o . ooo 
o . ooo o . ooo 
o . ooo o . ooo 
o . ooo o . ooo 
0 . 000 o . ooo 
1Determination group. 
2 . Sample period . 
Plasma 
o . ooo 
o . ooo 
o . ooo 
o . ooo 
0 . 156 
o . ooo 
3saline control. 
4 Low level manganese test group. 
5High level manganese test group. 
Formed 
o . ooo 
o . ooo 
o . ooo 
o . ooo 
o . ooo 
o. ooo 
Plasma Formed 
0 . 108 0 . 000 
Cl. 029 0 . 1 14 
o .448 0 � 654 
o .407 0 . 585 
0 . 303 0 .474 
0 . 398 0 . 146 
Group 3 8 
Plasma Fonned 
0 . 069 o . ooo 
0 . 057 0 . 000 
0 . 038 o . ooo 
0 . 118 o . ooo 
0 . 062 0 . 000 
0 . 098 0 . 000 
6Plasma concentrations of manganese in parts per million. 
?Formed element concentrations of manganese in ppn . 
8rntermediate level manganese test group . 
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TABLE 6.  ANALYSIS OF VARIANCE 
Basis 
RBC 
Count 
WBC 
Count 
Reticulocyte 
S ource 
T otal 
Treatment 
Time 1 
T r .  x Ti . 2 An. in T r .  
Duplicates 
Total 
Treatment 
Time 
Tr . x Ti . 
An. in Tr . 
Duplicates 
T otal 
Treatment 
Time 
Tr. x Ti . 
An .  in T r .  
Duplicates 
d.f. 
321 
3 
5 
15 
137 
161 
321 
3 
5 
15 
137 
161 
321 
3 
5 
15 
137 
161 
1
Treatment by time interacti on . 
2Animals in treatments .  
Suro of Mean 
Squares S quare 
277.0989 
10.4540 3.4847 
8. 9890 1. 7978 
38. 7496 2. 5833 
210. 2570 1.5347 
8. 6493 
1280. 8591 
170 . 5358 56.8453 
9. 7869 1. 9574 
i 41. 9360 2. 7957 
1013.1684 7. 3954 
45. 4320 
221.8510 
17 .0409 5 . 6803 
5. 2654 1.0531 
25 .1259 1. 6751 
. 149. 6998 1.0927 
24. 7250 
3symbology : highly significant, ** ; significant , * •  
F Rati o  
2. 2706 
1.1714 
1. 6833 
7 . 6866**3 
0. 2647 
0 . 3780 
5 .1984** 
0 . 9638 
. 1. 5330 
Overall S .D.  
Mean 
7. 2929 0 . 2318 
10 .1926 0 . 5321 
1. 2593 0. 3919 
CD ....,.., 
' 
Basis 
PCV 
Hemoglobin 
S ource 
T otal 
Treatment 
T ime 2 Tr.  x Ti
;J Remainde 
T otal 
Treatment 
Time 
Tr.  x Ti . 
Remainde r 
d . f . 
161 
3 
5 
15 
137 
161 
3 
5 
15 
137 
TABLE 6 CONTINUED 
Sum of Mean 
Square s S quare 
301092. 0000 
103 . 3258 34.4420 
36. 7607 7 . 3521 
71 . 3242 4. 7549 
1534. 3940 1 1 . 2000 
32498. 6000 
12. 8647 4. 2882 
26. 3542 5 . 2708 
14.4369 0.9625 
222 . 7268 1 . 6257 
1 Symbology : highly significant , ** ; significant , * ·  
2
Treatment by time interacti on.  
3s ource of error mean square . 
F Ratio 
3 . 075* 1 
0 .656 
o .425 
2 : 638 
3. 242** 
0. 592 
Overall 
Mean 
43 . 1 180 
. 14. 1453 
S . D .  
3 . 3230 
1 . 3323 
°' °' 
TABIE 7. ANALYSIS OF VARIANCE 
Basis 
MCH 
MCV 
MCHC 
S ource 
Total 
Treatment 
Time 2 Tr. x Ti. 
) An. in Tr. 
Duplicates 
Total 
Treatment 
Time 
Tr. x Ti. 
) An. in Tr. 
Duplicates 
Total 
Treatment 
Time 
Tr. x Ti.4 Remainder 
d. f .  
321 
3 
5 
15 
137 
161 
321 
3 
5 
15 
137 
161 
161 
3 
5 
15 · 
137 
Sum of Mean 
Squares Square 
1681. 2400 
112.4415 37.4805 
114.8764 22.9752 
241. 9417 16. 1294 
1 144. 6256 8. 3549 
67. 3548 0 . 4183 
13680.0891 
563 . 6884 187 .8961 
673 . 7792 134 . 7558 
2095 . 2690 139. 6846 
9735 .4997 71.0620 
611.8526 
174411.9434 
46. 2648 15 .4216 
110.1142 22 .0228 
83. 6929 5 . 5795 
531. 7196 3. 8812 
1 
Symbology : highly significant , ** ; significant , * ·  
2Treatment by time interaction. 
3
Animals in treatments ( s ource of error · mean square) . 
4 
S ource of error mean square . 
F Ratio 
4. 486**1 
2. 750* 
1.930* 
2. 644 
1 .896 
1. 966* 
3.973** 
5 . 674** 
1 . 438 
Overall S.D. 
Mean 
19. 6026 o . 6468 
59. 7839 1. 9494 
32 .8353 1. 2761 
OJ '° 
. TABLE 8 . ANALYSIS OF VARI A NCE , DIFFERENTI AL COUNT 
Basis 
Eosinophile 
Bas ophile 
S ource 
Total 
Treatment 
Time 2 Tr. x Ti . 3 An .  in T r .  
Duplicate s  
Total 
Treatment 
Time 
Tr. x Ti . 3 
An. in Tr. 
Duplicates 
d . f .  
321 
3 
5 
15 
137 
161 
321 
3 
5 
15 
137 
161 
TABIE 8 CONTINUED 
Stnn of Mean 
Squares Square 
1001.3199 
49 .5582 16.5194 
181. 6765 36.3353 
79 .4787 5 . 2986 
583. 1065 4. 2562 
107.5000 
499.8882 
40 . 5000 13. 5000 
33 . 7170 6. 7434 
22 . 8843 1. 5256 
316 . 7869 2. 3123 
86. oooo 
1 Symbology : highly s ignificant , ** ; s ignificant , * •  
2
Treatment by t"irne interaction .  
3Animals in treatment s ( s ource o f  error mean square ) . 
F Ratio 
3 .8813* 1 
8.5370** 
1. 2449 
5 .8383** 
2 .9163* 
0. 6598 
Overall 
Mean 
1. 6863 
0.9814 
s . D .  
0.8171 
0 . 7309 
'° � 
